Mississippi State University

Scholars Junction
Theses and Dissertations

Theses and Dissertations

8-6-2021

Consequences of external factors on placental and offspring
development and using melatonin as a potential therapeutic
Dana S. Reid
S.Dana.Reid@gmail.com

Follow this and additional works at: https://scholarsjunction.msstate.edu/td

Recommended Citation
Reid, Dana S., "Consequences of external factors on placental and offspring development and using
melatonin as a potential therapeutic" (2021). Theses and Dissertations. 5195.
https://scholarsjunction.msstate.edu/td/5195

This Dissertation - Open Access is brought to you for free and open access by the Theses and Dissertations at
Scholars Junction. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of
Scholars Junction. For more information, please contact scholcomm@msstate.libanswers.com.

Consequences of external factors on placental and offspring development and using melatonin as
a potential therapeutic
By
TITLE PAGE
Dana S. Reid

Approved by:
Caleb O. Lemley (Co-Major Professor)
Derris D. Burnett (Co-Major Professor)
Thomas W. Geary
Jean Feugang
Trent Smith
Jamie E. Larson (Graduate Coordinator)
Jane A. Parish (Interim Department Head)
Scott T. Willard (Interim Dean, College of Agriculture and Life Sciences)

A Dissertation
Submitted to the Faculty of
Mississippi State University
in Partial Fulfillment of the Requirements
for the Degree of Doctor of Philosophy
in Agriculture
in the Department of Animal and Dairy Sciences
Mississippi State, Mississippi
August 2021

Name: Dana S. Reid
ABSTRACT
Date of Degree: August 6, 2021
Institution: Mississippi State University
Major Field: Agriculture
Major Professors: Caleb O. Lemley; Derris D. Burnett
Title of Study: Consequences of external factors on placental and offspring development and using
melatonin as a potential therapeutic
Pages in Study: 175
Candidate for Degree of Doctor of Philosophy
Early life is critical for the development of an organism. External factors alter placental
efficiency which can lead to consequential effects. The objective of the current study was to (1)
examine placental characteristics and molecular factors affected by nutrient restriction (2)
evaluate the mitigating properties of melatonin in a nutrient restricted pregnancy in regard to
circadian, myogenic and adipogenic factors in fetal muscle and (3) evaluate the effects of
prenatal and postnatal melatonin supplementation on offspring performance.
In study 1, cows were fed a control (CON) or a 60% restricted (RES) diet from day 140
to 240 of gestation. Animals were slaughtered for placentome collection. Nutrient restriction
increased vessel perimeter, downregulated genes related to blood vessel development, and
upregulated ribosomal and translation factor expression. In lieu of downregulated vessel
development, a compensatory effect geared towards nutrient-transport apparent.
The 2nd study utilized spring-calving and fall-calving heifers in two trials with a 2 x 2 x 2
factorial design. Treatments were adequately-fed (ADQ) or 60% restricted (RES) dams along
with melatonin (MEL) or no melatonin (CON) from day 160 to 240 of gestation. Cesarean

sections were performed either in the morning (AM) or afternoon (PM). Circadian, myogenic
and adipose-related factors in fetal loin muscle (LM) were analyzed. Fetal LM from the springcalving (fall) group experienced a downregulation of circadian genes, myogenic genes and
tendency for downregulation in lipolysis genes. Fetal LM collected from the fall-calving
(summer) group had interactions in myogenic expression. Results demonstrate photoperiod and
seasonal effects on nutrient restriction and melatonin supplementation in regard to tissue
prioritization.
In study 3, melatonin was supplemented to calves during the prenatal and postnatal
period in a 2 x 2 factorial design Supplementation did not alter offspring performance. A lack of
differences may be attributed to similar endogenous melatonin levels in dams. Despite no
differences in calf performance, tendencies for decreased milk yield and fat were observed in
MEL versus CON dams. This demonstrates that melatonin may influence feed efficiency in
calves that receive less nutrients during early life. The programming effects of melatonin after
birth appear to be low.
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CHAPTER I
REVIEW OF LITERATURE
1.1

Developmental Programming
Developmental programming generally refers to the alteration of an organism’s

developmental trajectory due to an insult or stimulation which consequently affects that
organism after birth and can extend onset adulthood (Lucas 1998; Waterland and Garza, 1999,
Waterland and Michels 2007). This includes the long-term effects of developmental
programming in utero, known as fetal programming. However, it also encompasses the longterm effects that can be programmed during the post-natal phase. These effects can be
manifested on a molecular, cellular, or gross morphological level. Overall alterations to the
physical environment during a time of development can lead to overall limitations in the
nutrients needed to foster overall development as well as harness a homeostatic response by the
developing organism in order to counter these limiting substrates needed for optimal group.
The emergence of research involving programming was made more eminent through
epidemiological studies. Historical events such as the Dutch famine of 1944-1945 have later
exposed the effects of maternal undernutrition during pregnancy, and its predisposing influence
on the development of chronic metabolic disorders, including onset obesity, cardiovascular
disorders and insulin resistance (Ravelli et al., 1976; Barker and Osmond, 1988; Rooji et al.
2006). These observations generated the ‘Barker hypothesis’, and later, the ‘developmental
plasticity hypothesis’ and ‘lactocrine Hypothesis’. The ‘Barker Hypothesis’ denotes the impact
1

of early life adversity, particularly the effect of prenatal adverse nutrition and its ability to
program negative consequences on metabolism in adulthood. The ‘developmental plasticity
hypothesis’ further expands on the significance of environmental cues during early life by
emphasizing that tissues have highest potential to undergo alterations during early life, which is
not limited to the prenatal phase, but can extend to the early postnatal phase. This hypothesis is
also in conjunction with the ‘Lactocrine Hypothesis’ developed by Bartol et al. (2008) which
proposed that milk-born active compounds result in lactocrine signaling which can shape the
trajectory of development into adulthood. This can be expounded upon with the alteration of the
neonatal uterine transcriptome based on whether gilts were fed milk or milk-replacer (Rahman et
al., 2016; Bartol et al., 2017). Furthermore, as a result of these milk-borne active compounds,
short-term and long-term effects from the nursing period can be observed, including postnatal
uterine morphometric alterations (Bartol et al., 2013).
1.1.1

Developmental Programming on Early Tissue Development
Reproductive tissues are highly regulated by external factors since early detection (or

lack) of the SRY gene expression in the mammalian Y chromosome. This process will determine
whether testicular development will occur through a series of transcription factor expressions,
including Sox9 (Chaboisser et al., 2004). Interruptions in specific gene expressions during
critical periods during embryo and fetal development can result in extreme alterations in
reproductive function, including improper gonad formation and its adjacent tissues (Chaboisser
et al., 2004). These can be influenced directly by those external factors or indirectly through the
alteration of hormonal signal pathways caused by external factors. Hormonal signaling pathways
can also have detrimental reproductive consequences during the postnatal phase. This is the case
in studies involving neonatal administration of hormones such as testosterone (Abbott and
2

Hearn, 1978). Similarly, neonatal exposures of progesterone and estradiol have been reported to
alter uterine morphometrics in developing heifers (Bartol et al., 1995). Other instances of
postnatal programming are indicated in drug administration such as phenobarbitone, which led to
altered cytochrome P450 enzyme activity (Bagley and Hayes, 1983), or in reproductive
physiology and behavior studies such as Chen et al. (2011) who reported on the programming
potential of lactocrine-active peptides the nursing period that can alter transcription factors and
hormonal signaling involved in reproduction of those offspring.
In addition to reproductive function, in livestock there is heavy emphasis on the influence
of developmental programming towards performance and quality of economically important
tissues, including muscle and adipose tissue. Myogenesis occurs during the prenatal phase and
can be segmented into two classifications: primary and secondary, both of which are completed
by birth. During the initiation of myogenesis, somites of the dermomyotome are exposed to the
expression of transcription factors Pax3/7, this is followed by a low expression of the helix–
loop–helix factor MYF5; this results in the development of the myotome (Jostes et al.1990;
Goulding et al. 1991; Kiefer and Hauschka 2001). Similarly, other helix–loop–helix myogenic
regulation factors (MRFs) are capable of shifting mesenchymal stem cells towards a muscle
lineage and fully developing them to mature muscle fibers. These include, myogenin (MYOG), as
well as family member MRF4 (or MYF6) and are shown to have redundant functions if MYF5
and MYOD are absent (Wang et al. 1997; Zhu and Miller, 1997). As the myotome further
develops, with the combined expression of MYF5 and MYOD, results in the full commitment
from precursor cells to myoblasts and the fusion of myoblasts into myotubes caused by MYOG
(Barnoy and Kosower, 2007). After birth, postnatal development involves muscle fiber size
increase (hypertrophy) and is highly dependent upon myogenic stem cells or satellite cells
3

(Konigsberg, Lipton, Konigsberg, 1975). In addition to these key transcription factors,
microRNAs have been identified to heavily regulate mRNA expression of these transcription
factors. This further emphasizes that developmental programming is a critical event in that there
are miRNAs only expressed during early development, as early as the embryonic stem-cell phase
that can impact these key transcription factors (Houbaviy et al., 2003).
Similar to muscle, adipose tissue emerges from the embryonic mesoderm. Initiation of
adipogenesis occurs when mesenchymal cells become committed to pre-adipocytes, these preadipocytes proliferate then undergo differentiation to adipocytes. This process begins during mid
gestation in ruminants (Feve, 2005; Gnanalingham, 2005; Muhlhausler, 2005) and is heavily
regulated by transcription factors, including CEBPA, which functions as an upstream
transcription factor (Freytag et al., 1994). This upstream expression results in the cascading
activating of the nuclear receptor, PPARG, which is the primary regulator of adipose
differentiation (Koutnikova et al., 2003). During the prenatal phase, hyperplasia primarily occurs
after parturition. After parturition, hyperplasia gradually decreases and diverts to hypertrophy.
Additionally, after lipids are synthesized and stored, lipogenic factors, such as stearoyl-CoA
desaturase (SCD), are responsible for lipid metabolism, including regulating the types of lipids
that are stored or metabolized. Enzymes such as SCD, which convert stearic acid to oleic acid,
hereby influence overall triglyceride content as well as saturated and unsaturated fatty acid ratios
in adipose depots, namely visceral fat, subcutaneous fat, intermuscular fat and intramuscular fat
(marbling). Conversely to adipogenesis, the multi-faceted function of fat can also shift to
lipolysis, depending on the physiological state of the organism. Key factors such as adiponectin
(ADIPOQ) are involved in fatty acid oxidation in muscle and the liver through receptor
pathways, and is also a mediator in adenosine monophosphate protein kinase (AMPK) regulation,
4

both of which are involved in glucose metabolism and lipolysis (Yamauchi et al., 2003).In
addition to the core adipogenic factors mentioned, miRNAs play an important role in adipocyte
differentiation (Esau et al., 2004).
1.2

Placental Efficiency
The optimal growth and development of fetal tissues are heavily reliant on the placenta.

During the prenatal phase, environmental factors can result in the alteration of the fetus. This is
especially prevalent during mid to late gestation when blood flow and capillary formation
substantially increases to facilitate fetal growth and development. Placental insufficiency can be
defined as the incapacity for the placenta to effectively transfer the appropriate level nutrients,
oxygen and waste products between dam and fetus (Kusinski et al., 2012), and it is the main
contributor to fetal growth restriction. The placenta relies on transcription factors that are needed
for angiogenesis, vasodilation tissue generation. (Ferrara et al., 1996; Sibley et al., 2004;
Kusinski et al., 2012). These factors are major contributors to blood flow, which appears to be
the most significant factor towards trans-placental exchange during gestation. In addition to these
factors, nutrient transporters play a major role in efficient uptake of substrates by the fetus. The
increase of blood flow was described early by Barcroft and Kennedy (1939) to increase as the
pregnancy proceeds, with the highest rate of blood flow occurring during the last trimester. It is
now established that blood flow is a critical factor when utilizing the Fick principle for
determination of nutrient/oxygen uptake during the postnatal phase: uptake = blood flow
(ml/min) x (arterial blood concentration – venous blood concentration) and during the fetal phase
as: uptake = blood flow (ml/min) x (venous blood concentration – arterial blood concentration)

5

1.3

External Factors Affecting Placenta Efficiency and Developmental Programming
There are several external or environmental factors that have a direct or direct impact on

developmental programming. An increase in the amount of fetuses present can restrict placental
efficiency. Despite an overall increase in total blood volume and uterine blood flow there is a
decrease in the uterine blood flow rate per fetus which results in limited oxygen and nutrient
transport (Pere and Etienne, 2000). The increase in number of fetuses exacerbates the condition
as Dwyer et al. (2005) reported on the increase of overall placental weight in ewes that gave birth
to twins and triplets compared to singletons. Despite the increase in placental efficiency (fetal-toplacental weight ratio) in the ewes that birthed twins and triplets over singletons, weights of the
triplets were less than that of the twins, which were both less than the weight of ewes that birthed
singletons; cotyledon number decreased in triplet groups. Furthermore, twins and triplets had a
delayed response towards standing and suckling. Similarly with cattle, Ferrell and Reynolds
(1992) reported that in cows with twins umbilical blood flow was greater when compared to
singletons. However, fetal oxygen uptake tended to be lower in twins. Fetal overcrowding
continues to be a hindrance in the swine industry. This is reflected in piglets with lower birth
weights (Milligan et al., 2002). As aforementioned, lack of oxygen can contribute to fetal
programming and can be independent of fetal overload. In rats hypoxic stress is shown to
contribute to a decreased placental efficiency in oxygen-restricted dams versus control,
additionally, offspring from restricted dams experienced diminished dilation and impaired
relaxation in femoral arteries (Giussani et al., 2012). This could be attributed to the
downregulation of molecular factors such as VEGF during placental insufficiency (Regnault et
al., 2003). Additionally, heat stress has been commonly known to reduce performance traits such
as growth (Broucek et al., 2009). Hyperthermic conditions have resulted in placental
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insufficiency and reduced placental and fetal sizes (Thureen et al., 1992; Arroyo et al., 2010).
This reduced placental insufficiency may be explained by pathways involving oxidative stress
since oxidative stress markers such as lipid peroxidation have been reported in heat stressed
animals (Jacobs et al., 2020). Other factors, such as transportation stress during pregnancy can
alter the offspring genome by DNA methylation which may cause epigenetic implications
(Littlejohn et al., 2018).
One of the most common and well-documented external factors that contribute to
developmental programming involves the diet of the mother (dam). Instances of undernutrition
or overnutrition, or lack of a key nutrient source, such as protein, fosters an adverse environment
for the fetus which result in either a manifestation of this adversity or a compensatory effect to
overcome such adversity. Of the aforementioned adversity that the offspring may attempt to
overcome, an ironic fate of negative effects may appear later in life as observed in
epidemiological studies.
1.4

Maternal Nutrient Plane on Performance in Early Life
From the literature, it is now established that diffusion-limited substances, including

oxygen and glucose are determined by blood flow rate (Reynolds et al. 2006). Therefore,
maternal diet plays a pivotal role in fetal programming, due to its direct role in influencing
placental efficiency and blood flow (Wallace et al., 2002). Compromised maternal diets have
been documented to alter uteroplacental hemodynamics (Lekatz et al., 2013) which can impact
fetal and neonatal attributes, including overall body weights and lagged organogenesis growth.
As aforementioned, in humans, maternal nutrient restriction increases the predisposition of
metabolic disorders later in life including diabetes, hypertension and heart disease (Barker et al.
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1990; Osmond et al., 2007); however, the timing of restriction is also a critical factor. Stein and
Susser (1975) reported on greater manifestations of programming during the Dutch famine with
lower birth weights observed following nutrient restriction during the third trimester compared to
the first two trimesters which experienced no differences. Maternal nutrient restriction can result
in growth retardation observed in fetal and birth weights and can even lead to retarded growth
during the weaning period and adulthood (Bernal et al. 2010). In addition to general nutrient
restriction, protein restriction can cause dire consequences to fetal development. Studies
involving protein supplementation have shown to mitigate maternal body weight loss by
improving birth weights, weaning weights, carcass weights in beef cattle (Stalker, Adams and
Klopfenstein, 2005; Stalker et al., 2006; Larson et al., 2009).
1.5

Maternal Nutrient Plane and Metabolism
The effects of maternal nutrient plane delve further than gross morphology, organ and

cellular structure alterations can result in an imbalanced metabolism in the organism. The overall
decrease in placental blood flow affects nutrient uptake, which limits necessary substrates for the
fetus. The mean uterine blood flow can decrease by about 30% in underfed ewes during the
resting phase, along with decreases in fetal blood glucose concentrations and glucose uptake
(Chandler et al., 1985). This can consequently program the fetus to modify metabolic processes
such as glucose uptake and insulin secretion. In the case of Robles et al. (2017) this suboptimal
glucose and insulin metabolism can be irreversible amid a radical shift from one adverse plane of
nutrition to another. The author utilized mares by feeding only forage to one group (F) while
feeding forage and cracked barley to another group (B) from mid-gestation until foaling. Foals
were reared under a control diet until 20 to 24 months of age when they were overfed (135% of
NRC requirements). The overfed diet resulted in colts from B mares having increased plasma
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insulin concentrations when compared to the F group. However at 24 months, horses from B
mares had a lower glucose to insulin ratio compared to the F group, suggesting a predisposition
for insulin resistance later in life in offspring from the F group. Concurrently, overfeeding
animals can also have negative impacts. Redmer et al. (2011), utilized an overfed sheep model to
demonstrate these detrimental effects. Ewes were fed either a control (C) or high-fed (H) diet
during the first two-thirds of gestation. During the last-third of gestation, the H group was
subdivided into either a continuation of the H diet or a switch to a low-fed diet (HL). The H and
HL groups had lower placentome weights and higher fetal to placentome ratios compared to the
control. The H and HL groups had lower fetal weights compared to the control as well as
reduced weights in the liver. The HL group had reduced pancreas weights compared to the C and
H group. However, there was a brain-sparing effect observed. The H and HL groups had lower
plasma glucose compared to C group and the HL group had lower plasma insulin levels
compared to C and H groups. Additionally, there was an up-regulation in angiogenic factors,
including VEGFA, in the H and HL group compared to the C group.
Fetuses with a lagged growth projection have shown to have the potential of experienced
imbalanced metabolic clearance excretion due to disproportionately smaller kidneys (Konje et
al., 1996). On the cellular level, intra-uterine growth restricted (IUGR) infant humans were
discovered to have lower nephron numbers (Hinchliffe et al., 1992). Similar results were
detected in rat models where protein and energy restrictive diets during gestation led to reduced
kidney size and nephron numbers (Langley-Evans et al. 1999). Alterations in organogenesis can
also be dependent on the stage of gestation during maternal restriction. In sheep, maternal
nutrient-restriction during early to mid-gestation increases organ size, including the kidneys
(Whorwood et al. 2001), but still had lower nephron numbers when compared to the control
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(Gopalakrishnan et al. 2005). In the case of the liver, Vonnahme et al. (2003) subjected sheep to
a control (CON) versus 50% nutrient-restriction (NR) in sheep from day 28 to 78 of gestation,
liver weights were lower in the NR group compared to the CON; however, the organ/fetal weight
ratio was higher in the NR group.
In addition to maternal nutrient restriction altering organs involved in metabolic
homeostasis, the time of restriction can also alter the extent of organ and tissue development
alteration. In a study by McCarty et al. (2020), beef cows were fed either a control diet control
(CON) or nutrient-restricted (NR) diet. On day 30 of gestation, dams were allotted in one of
three treatments: (1) CON from day 30 to 190 (CON), (2) CON from d 30 to 110 followed by
NR from d 110 to 190 of gestation (C/NR) or (3) NR from d 30 to 110 followed by CON from d
110 to 190 of gestation (NR/C). Cows were slaughtered on day 190 of gestation for pancreas
collection and analysis. Pancreas weight from fetuses was decreased in C/NR group compared to
CON group. Additionally, a decrease in fetal serum insulin levels from C/NR group was
observed compared to the CON group. Pancreatic insulin levels were the lowest in the C/NR,
followed by the NR/C at an intermediate in respect to the CON. Furthermore, overall pancreatic
β-cell number was decreased in C/NR and NR/C groups compared to the control; and increased
β-cell apoptosis was the highest in C/NR group followed by NR/C group compared to the
control. This study also reinforces the narrative that different stages of gestation can have more
consequential programming effects.
Compared to overall energy imbalance, protein-imbalanced diets have similar detrimental
effects. Petrik et al. (1999) delved further into the cellular and molecular effects of a low-protein
diet during the gestation period. Rats were provided an isocaloric diet with either low (8%; LP)
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or high (20%; HP) protein from day 1 of gestation. Subsets of rats were sacrificed to collect
pancreatic samples from fetal age 19.5 days (F19.5) to 21 days postpartum. In addition to lower
fetal and postnatal body weights, offspring from LP dams experienced lower pancreatic weights,
a lower mean islet area by 50% and a lower mean beta cell mass by 50% compared to offspring
from HP dams. Furthermore, a lower insulin/glucagon ratio and lower IGF2 mRNA expression
was observed in the offspring from the LP group compared to HP diet.
1.6

Maternal Nutrient Plane and Reproduction
Maternal nutrient plane extremities (over and underfed) have also caused detrimental

effects in developmental programming of reproductive tissues. Mice subjected to maternal
undernutrition reduces the number of primordial, primary and antral follicles (Bernal et al., 2010)
The authors conclude that this may be a result due to alterations in gene expression alterations
related to folliculogenesis and steroidogenesis, including ovarian GDF-9, P450 cytochrome A1
and ER-beta. Concurrently, Mossa et al. (2009) found that heifers born from undernourished had
60% less antral follicles ≥ 3mm in diameter. Conversely, Weller et al. (2016) demonstrated that
maternal overnutrition caused reduction in fetal ovarian reserve as well as possible
overexpression of steroidogenic genes. In horses, maternal undernutrition followed by a high-fed
postnatal diet is reported to result in delayed testicular maturation (Robles et al. 2017). In
addition to an undernourished diet, a protein restricted diet can be detrimental to fetal
programming. This was observed study by Godfrey et al. (1996) who reported that low maternal
intakes of protein derived from meat and dairy were associated in lower placental weights and
birth weights in humans. More geared towards underdeveloped reproductive tissues, in a study
by Zambrano et al. (2005) where pregnant rats were provided either a control or a 50% protein
restricted diet. After birth, the offspring were divided in half and allotted a new diet: either
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control (C) or protein restricted (R). This created 4 treatments: CC (control-control) RR
(restricted-restricted), CR (control-restricted) or RC (restricted-control). Compared to the CC
group, testicular descent was delayed by 2.1 days in the CR group, 2.2 days in the RC group and
4.4 days in the RR group. Testicular weight was reduced in the CR and RC groups at days 25
and 70 postnatally, and sperm count was reduced at days 270 postnatally in the RR and RC
groups.
1.7

Maternal Nutrient Plane on Skeletal Muscle Development
The effects of maternal diet on muscle transcriptomic factors are highly influential as

demonstrated by Peñagaricano et al. (2014) who reported on 224 and 823 genes differential
expressed genes in sheep fetal loin muscle derived from dams fed isocaloric diets either dried
distiller grains, corn or hay. Therefore, alterations due to nutrient plane can be further reflected
depending on the stage of gestation. In cattle, during the first 2 months of gestation, primary
muscle fibers development is initiated, however the majority of development occurs after 2
months of gestation (Russell and Oteruelo, 1981). By approximately day 210 of gestation,
skeletal muscle development shifts from hyperplasia to predominantly hypertrophy; this is also
the similar case in sheep where hypertrophy occurs at approximately day 105 of gestation (Du et
al., 2010; Yan et al., 2013). Therefore, maternal nutrient restriction can potentially affect muscle
fiber number or size (Greenwood et al., 1999). This is attributed to certain molecular pathways
that regulate translation and protein accretion. In a study by Zhu et al. (2004), ewes consumed a
control diet versus a 50% feed restriction during day 28 to 78 of gestation. Ewes were
slaughtered at day 78 of gestation and fetal loin muscle collection and analysis showed a 43%
reduction in mTOR (mammalian target of rapamyosin) phosphorylation, a promoter of protein
translation. Zhu et al. (2006) also conducted a similar time and feed restriction, except where
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lambs were born and raised on an ad libitum diet. Loin muscle samples collected from lambs at 8
months of age showed that the lambs from the restricted-fed dams experienced a decrease in
muscle fiber number and an increased ratio of myosin type IIb fibers and a corresponding
reduction of myosin type IIa fibers. Additionally, the activity of the fatty acid oxidation
regulation enzyme, CPT-1, was decreased in the lambs born from restricted dams;
simultaneously the loin muscle intramuscular triglyceride content was higher in lambs born from
restricted dams. Protein and amino acid supplementation can impact the outcome of muscle
characteristics. Mortensen et al. (2010) reported that supplementing taurine to mice born from
dams fed a low-protein diet partially prevented 30% of altered gene expression in the liver and
46% of altered gene expression in skeletal muscle alterations. Also, Berard and Bee (2010)
reported that dietary L-arginine resulted in a greater percentage of primary myofibers and a
lower secondary/primary myofiber ratio in the semitendinosus muscle.
1.8

Maternal Nutrient Plane on Adipose Tissue Development
Adipogenesis occurs during mid gestation in ruminants (Gnanalingham et al., 2005;

Muhlhausler et al., 2007) overlapping with secondary myogenesis during early life as they are
derived from the same mesenchymal stem cells. However, instances of severe shifts in maternal
nutrient plane such as overnutrition have been shown to upregulate adipogenic genes, including
PPARG, and Adiponectin and increase glucose and insulin concentrations (Muhlhausler,
Duffield and McMillen, 2007). In the process of adipose upregulation, there is a simultaneous
downregulation of myogenic factors which leads to the potential of myocytes differentiating into
adipocytes (Tong et al., 2009). This can be explained by the downregulation of factors involved
in the Wnt/B-catenin signaling pathway, an upstream process that facilitates the expression of
Myogenic Regulatory Factors, including MYF5 and MYOD (Armstrong and Esser, 2005; Tong et
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al., 2009). In addition to myogenic downregulation, phosphorylated AMPK, which catalyzes fatty
acid oxidation and inhibits lipid synthesis through fatty acid oxidation pathways involving
Interleukin-6, p38 mitogen-activated protein kinase (MAPK), and PPAR-alpha (Carey et al.,
2006; Ravnskjaer et al., 2006; Yoon et al., 2006) are also downregulated during events of
overnutrition and obesity during gestation (Tong et al., 2008). As a result of alteration of these
transcription factors, phenotypical morphometrics can have a long-term effect on offspring. Zhu
et al. (2006) reported that their 8-month-old lambs from ewes on a 50% restricted diet during
early gestation had a tendency for a higher carcass weight compared to the control group.
Furthermore, upon analyzing fat depots, proportions of kidney and pelvic fat increased;
meanwhile loin muscle and semitendinosus weights tended to decrease. However, Long et al.
(2021) treated beef heifers to a 70% restricted diet at day 158 of gestation. After parturition,
heifer calves were kept with their respective dams on pasture and provided 100% feed
requirements for the lactation period (National Research Council). Two weeks after the weaning
period (210 days postnatal; PND) heifers were fed a high grower ration. At day 305 PND, heifers
were fed finishing ration ad libitum until slaughter at day 485 PND. A higher amount of internal
fat content was reported in calves born from restricted dams compared to the control group.
Heifers born from the restricted dams experienced no differences in body weight, rib eye area (P
= 0.08) and last rib back fat. Additionally, no differences were observed in cook time, cook yield
and Warner-Bratzel shear force in heifers born from restricted dams versus the control group.
However, whole pituitary weights were lower in calves born from restricted dams versus the
control. Factors such as intensity of adverse nutrient plane and molecular factors acting in a
compensatory format may contribute to these results.
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1.9

Melatonin
Melatonin (N-acetyl-5-methoxytryptamine) is an amino acid hormone that is secreted in

the pineal gland in the brain. It is produced by the following reaction: Tryptophan is converted to
5- hydroxytryptophan (5HT) by tryptophan hydroxylase (TPH). After which, 5HT is converted
by arylalkylamine-N-acetyltransferase (AANAT) to N-acetylserotonin. N-acetylserotonin gains a
methyl group from 5-adenosylmethionine under the influence of hydroxyindole Omethyltransferase (HIOMT) to finally yield melatonin. Its secretion is based on the 24-hour
circadian system of the suprachiasmatic nucleus of the hypothalamus. This region has evidence
of upregulations of melatonergic enzymes, TPH, AANAT and HIOMT mRNA levels in the day
and subsequent decreases during the night (Bernard et al., 1999). Therefore, these combined
circadian and circannual systems allow melatonin to play an important part in physiological
processes within the body.
1.9.1

Melatonin and Vasculature
Melatonin’s ability to affect the vascular system is due to the presence of melatonergic

receptors: MT1, MT2 on endothelial cells (and to a lesser extent MT3 in cardiac tissue).
Melatonergic receptor pathways are proposed to have vasodilatory effects through a cascade of
events (Paulis and Simko, 2007). When melatonin binds to MT2 receptors, it activates the Gcoupled protein to activate increases cystolic Ca2+ ions (Brydon et al. 1999). The influx of Ca2+
ions activates the catalytic enzyme, nitric oxide synthase (Mittal and Jadhav, 1994), which is
known to promote nitric oxide (NO) production. Nitric Oxide production is then believed to
cause the subsequent relaxation of vascular smooth muscle cells through activation of the
guanylate cyclase (sGC) and cyclic Guanosine Monophosphate (cGMP) pathway (Roy and
Garthwaite, 2006). Conversely, melatonin can have vasoconstrictive properties when bound to
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melatonin receptors (MT1 and MT2) located on vascular smooth muscle cells. As proposed by
Paulis and Simko (2007), it is believed that the similar influx of cystolic Ca2+ ions caused by Gcoupled protein, instead causes a direct effect of contracting on smooth muscle cells (Brydon et
al., 1999) as well as a G-inhibitory (Gi)-coupled protein that inhibits the adenylated cyclase (AC)
and cyclic Adenosine Monophosphate (cAMP) pathway (Brydon et al., 1999).
This dual signaling pathway is believed to be the reason for melatonin’s ability to
regulate cardiovascular-related properties, including reducing blood pressure in patients
predisposed with hypertension (Scheer et al., 2004), and reducing renal blood flow while
simultaneously increasing forearm blood flow in humans (Cook et al., 2011). Interestingly,
Renshall et al. (2018) supplemented melatonin among gestating wildtype, eNOS knockout and
placental IGF2 knockout mice and found that melatonin supplementation increased fetal weights
in wildtype mice, but not in knockout mice, further solidifying these proposed pathways leading
to improved offspring performance. Melatonin has shown to induce contractile responses in in
vitro caudal arteries in rats through nerve stimulation, additionally, when arteries were treated
with MT receptor antagonist, luzindole, potentiation of contractile response decreased (Krause,
Barrios, Duckles, 1995). Using diabetic rat models, melatonin was shown to reduce
vasoconstriction of the aorta in melatonin-treated cultures (Wu et al., 1998). Moreover ReyesToso et al. (2002), found that phenylephrine-induced vasoconstriction was lowered in melatonintreated in mildly-diabetic rats. Also melatonin induced serotonin-induced vasoconstriction in
severely-diabetic rats after exposure to high glucose. In an in vitro rabbit study, results
demonstrated that melatonin potentiates vasodilator properties of acetylcholine while
simultaneously diminishing the contractility effects of norepinephrine and phenylephrine (Anwar
et al., 2001). From an in vivo study, melatonin showed a similar effect in inhibiting
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vasoconstriction of the aorta and mesenteric beds of spontaneously hypertensive rats (Girouard
and Champlain, 2004).
These differential changes in blood flow, can also have implications towards metabolism
and homeostasis. Sartori et al. (2009) reported on the effects of melatonin supplementation on
glucose homeostasis and endothelial vascular function in high-fat- diet-feed insulin resistant
mice. In this study, five-week old C57/BL6 mice were fed either a high-fat diet (HFD) or a
normal chow diet (NC) for ten weeks. During the last eight weeks of the trial, mice received
either melatonin or vehicle through their drinking water. Results showed that in HFD-mice,
although blood glucose concentrations were similar between melatonin-treated vs vehicle-treated
mice, the melatonin-treated group had lower basal insulin plasma concentrations compared to
vehicle-treated mice by almost 50%. Additionally, the HOMA index (insulin resistance marker)
was lower in melatonin-treated versus vehicle-treated HFD-fed mice, indicating more insulin
sensitivity. From the euglycemic hyperinsulemic clamp studies in HFD-fed mice, a higher
glucose infusion rate is needed to maintain euglycemia during hyperinsulemia. Melatonin-treated
mice experienced a higher glucose infusion rate compared to vehicle-treated mice. Additionally,
melatonin improved glucose tolerance in HFD-fed mice due to observed lower plasma glucose
concentrations recorded from each time point collected. Therefore, melatonin may have the
capacity to lower insulin resistance. In HFD-fed mice, data collected from laser Doppler blood
flow measurements showed that melatonin increased blood flow by approximately 50% when
compared to vehicle-treated groups. Also, the melatonin group had improvements in insulin’s
ability to induce serine 473 phosphorylation of Akt as well as serine 1177 phosphorylation of
eNOS in aortas of HFD-fed mice. These results indicate melatonin’s involvement in improving
insulin-mediated vasodilation through Akt-mediated phosphorylation of eNOS.
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1.9.2

Melatonin and Placental Hemodynamics
Supplementing melatonin alters hemodynamic characteristics in several animal models.

In sheep, Lemley et al. (2012) utilized a 2 x 2 factorial design in a mid to late-gestation ovine
model. Nulliparous ewes carrying singletons were subjected to either adequate (ADQ) or 60%
NRC restricted feed (RES) diet. Additionally, ewes either received melatonin (MEL) or did not
receive 5mg of melatonin (CON). This produced four groups: CON-ADQ, CON-RES, MELADQ, and MEL-RES; treatment was provided from day 50 to 130 of gestation. A treatment x
day interaction was observed where MEL dams had an increase in umbilical artery blood flow
from day 60 to day 110 of gestation and again at day 130 of gestation. Umbilical artery blood
flow was higher by 17% in MEL dams compared to con dams. Additionally, cotyledonary
capillary surface area (CSA) increased by 25% in MEL dams compared to CON dams. For
uterine artery indices, there was a treatment by diet interaction where the MEL-RES group had
an increase in the gravid uterine artery resistance index (RI) versus the MEL-ADQ group.
Meanwhile in the non-gravid uterine artery, there was a treatment x diet interaction the
pulsatility index (PI) was decreased in the MEL-ADQ group versus CON-ADQ group. These
increases based on diet and treatment are believed to be reflected in improved fetal
characteristics observed, including an increased ponderal index and abdominal girth in the MELADQ group. In a similar animal and treatment design, Lemley et al. (2013a) demonstrated the
potential of amino acid uptake as a critical factor in limitation of nutrient availability and
utilization by the fetus and how melatonin alterations can have favorable consequences in amino
acid (AA). There was a treatment x diet interaction in fetal venous - arterial difference of total
alpha-AAs, in which concentration differences decreased in fetuses from CON-RES dams versus
CON-ADQ dams. Meanwhile the MEL-RES ewes were increased at a level comparable to that
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of the CON-ADQ ewes. Eifert et al. (2015) also utilized a similar 2 x 2 factorial design along
with similar treatment groups and melatonin dose (MEL-ADQ, MEL-RES, CON-ADQ, CONRES) in order to determine the effects of melatonin during maternal nutrient restriction on ovine
placental vascularity and cell proliferation. On day 130 of gestation, ewes were euthanized for
uterine and fetal harvesting and dissection. Caruncles and cotyledons were separated, flash
frozen and stored. Results showed that at day 130 of gestation, there was a 20% increase in
umbilical blood flow in MEL ewes versus CON ewes. Meanwhile, for uterine blood flow, there
was a diet effect of a 20% decrease in uterine blood flow of RES ewes versus ADQ ewes. A
treatment x diet interaction for maternal RNA concentrations in caruncular tissue, in which the
MEL–RES dams experienced an increase when compared to the CON–RES and MEL–ADQ
dams. A main effect tendency of increased Ki-67 positive cell percentage (cell proliferation
indicator) observed in the cotyledon tissue of MEL group compared to CON group. In terms of
capillary measurements, a treatment x diet interaction was observed, with a decrease in
caruncular capillary area density (CAD) in the MEL–RES group compared to CON–RES group.
A tendency for a treatment x diet interaction was observed in cotyledonary average crosssectional area per capillary (APC). This decreased in the MEL–RES group compared to the
CON–ADQ, CON–RES, and MEL–ADQ groups.
In a second study by Eifert et al. (2015) to determine the effects of a melatonin receptor
antagonist on vasculature, primiparous ewes were administered surgeries at day 61 of gestation
using Alzet mini-osmotic pumps with prepared melatonin (MEL-) luzindole (LUZ-) or vehicle
(CON-) solutions for local infusion until day 90 of gestation when euthanasia occurred.
Caruncular, cotyledonary tissues were collected, flash frozen and properly stored. Results
showed there were no differences in placentome weights across treatments. However, there was
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a decrease in caruncular weight in MEL- and LUZ- groups versus the control. Additionally,
abdominal growth was greatest in the MEL- group followed by the CON- group, then the LUZgroup. Capillary measurements showed a tendency for increased CAD and APC in LUZ- versus
CON-. Meanwhile, no differences were found in the MEL-group.
Lemley et al. (2013b) further delved into validating melatonin’s vascular-altering abilities
during gestation by incorporating luzindole, a known melatonin receptor antagonist. Ewes
underwent surgery at day 62 of gestation using Alzet mini-osmotic pumps with prepared
melatonin (MEL) luzindole (LUZ) or vehicle (CON) solutions for local infusion until day 90 of
gestation when euthanasia occurred. Throughout the trial, blood flow was collected. Caruncular,
cotyledonary tissues were collected, flash frozen and properly stored. Data analyzed showed a
treatment x day interaction where on day 80, there was a decrease in umbilical blood flow in the
LUZ group compared to the CON or MEL groups. Additionally, by day 90, the MEL group
experienced increased blood blow compared to the CON and LUZ group. Overall, there was a
main effect of treatment on the average umbilical blood flow after the infusions were
administered, with the LUZ experiencing lower average umbilical blood flow. Similar results
occurred for the blood flow rate of the descending aorta, as well as a decreased Resistance Index
(RI). Caruncle weight at day 90 was decreased in the MEL and LUZ groups compared to the
CON group. Placental efficiency in the MEL group was increased compared to the LUZ group.
In dairy cattle, melatonin similarly alters uterine hemodynamics. Brockus et al. (2016a)
conducted a study where the first study involved supplementing heifers with either 20 mg of
melatonin (MEL) or none (CON) via feed to pregnant Holstein singleton heifers from days 190
to 262 of gestation. The authors found that average ipsilateral uterine artery and total uterine
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blood flow increased in the MEL group versus the CON group by 32% and 25%. A treatment x
day interaction was observed with pulse pressure, where the MEL group experienced an increase
compared to the CON group. There was a treatment effect on maternal heart rate with the MEL
group experiencing a 9% increase compared to the CON group. Additionally, there was a
reported treatment x age interaction, where calves born from MEL dams had and an increased
heart girth at week 8 as well as increased body weight at weeks 8 and 9 compared to calves born
from CON dams.
McCarty et al. (2018) also demonstrated the ability for melatonin to alter hemodynamics
during gestation and reported improved characteristics in offspring. Commercial beef cows and
heifers were allotted to one of two treatments: melatonin-implanted (MEL) or no melatonin
implants (CON) at day 180 of gestation. Implants were given on day 180, 210 and 240 of
gestation in order for a slow-release supply of melatonin until parturition. Of the dams, a subset
of heifers underwent Cesarean sections. The remaining were allowed to give birth and singleton
male calves were measured for morphometrics. A subset of male calves were castrated at day
195 for testicular morphometric measurements. Results demonstrated a tendency for a treatment
x day interaction for the MEL heifers tended to have increased blood flow, ipsilateral uterine
artery, and contralateral uterine diameter and had an increase in contralateral uterine blood flow
at day 240 compared to CON heifers. Several main effects of treatment were observed in cows,
including MEL cows experiencing an increased ipsilateral uterine artery blood flow and
Ipsilateral Mean Velocity compared to the CON cows. The MEL group also tended to have a
treatment x day interaction, where diameter in MEL cows tended to be larger on day 210. In
heifers, total uterine artery blood flow experienced a treatment x day interaction, with MEL
heifers at day 24 versus CON heifers, while Cows had a main effect where the MEL group had
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increased total uterine blood flow. For placentome characteristics, percent area decreased in
MEL heifers versus CON heifers. Cotyledonary angiopoietin (ANGPT1) tended to increase in
MEL heifers compared to CON. Postnatal measurements demonstrated increased Curved Crown
Rump length (CCR), Ponderal Index and weaning weights in calves born from MEL dams.
Additionally, castration measurements showed greater testicular weights and scrotal
circumference length. These uteroplacental studies allude to the positive background of
development in utero, and its result into onset post-natal and pubertal development.
1.9.3

Melatonin and Antioxidant properties
In addition to altering vasculature through melatonin receptors, melatonin contains potent

antioxidant properties that can reduce free radicals, including reactive nitrogen species and
reactive oxygen species (ROS). Free radicals appear to originate mostly from mitochondrial
metabolism and results in lipid peroxidation (Gibb et al., 2014). Tissues that undergo a severe
imbalance in oxygen concentration can undergo oxidative stress (Danilov and Fiskum, 2008).
Since the demand for oxygen for transport from the dam to the fetus is so high, the placenta is an
organ susceptible to ROS. Oxidative stress can result in damage to cells by membrane and
nuclear damage, apoptosis and reduced blood flow to tissues.
Melatonin is hypothesized to reduce ROS via two mechanisms: firstly, the amphiphilic
nature of melatonin allows for penetration beyond the cell membrane into intra-cellular
components where it can scavenge free radicals (Hardeland, 2005; Jou et al., 2007; Reiter et al.,
2008; 2009). Secondly, melatonin binds to MT1 receptors, which signal activation of AMPK
phosphorylation (Zhu et al., 2019). AMPK phosphorylation activates/upregulates anti-oxidative
endogenous enzymes involved in scavenging oxidative species (Nguyen et al., 2014; 2015; Zhu
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et al., 2019). This pathway is believed to result in activation of endogenous antioxidant enzymes
(Reiter et al; 2008; 2009), and can increase total antioxidant capacity (TAC) and reduced
Malondialdehyde (MDA) and Lipid Peroxidation.
These antioxidant pathways can explain melatonin’s ability to improve sperm parametrics
in semen extender and in vitro culture media. Optimal melatonin concentrations have resulted in
higher total and progressive motility, total normal morphology, and membrane integrity in
cryopreserved bull and chilled ram semen and chilled stallion semen (Ashrafi et al., 2011;
Ashrafi et al., 2013; Izadpanah et al., 2015). Similar results were found in human semen
subsequently challenged to oxidative stressors- H2O2 and a calcium-releasing agonist, along with
less apoptotic cells (Espino et al., 2010). Melatonin-supplemented semen extender improved
motility, acrosome and membrane integrity as well as mitochondrial membrane potential in
cryopreserved rooster semen (Appiah et al., 2019; Mehaisen et al., 2020) and in cryopreserved
and oxidative stress-induced rabbit spermatozoa (Zhu et al., 2019). Furthermore, Zhu et al. 2019
determined that AMPK activation and lipophilic properties of melatonin led to increased
antioxidant enzyme activity and glutathione levels and decreased lipid peroxidation. Moreover,
these benefits were negated or inhibited in sperm treated with melatonin and luzindole. There is
also evidence that melatonin mitigates DNA fragmentation in cryopreserved ram semen (Succu
et al., 2011). Similarly, in vitro incubated semen that was treated with melatonin showed reduced
apoptotic sperm numbers and increased plasma membrane permeability for up to 3 hours in
stallions (Balao da Silva et al., 2011). Furthermore, in addition to improved sperm quality,
melatonin may potentially have a consequential effect on embryo development. Jang et al.
(2009) performed a 2 x 2 factorial in vitro study on sperm quality and embryo development by
using porcine oocytes fertilized by semen treated either with or without melatonin in the
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presence or absence of H2O2 (CON, MEL, H2O2, MEL+H2O2). Overall, the MEL group showed
to have increased sperm motility, viability, survival rates and membrane integrity when
compared with other groups. Moreover, the embryos fertilized with the MEL-treated sperm had
an increased blastocyst developmental rate when compared to other groups. Despite the
promising potential benefits mentioned previously, the majority of these studies establish that
excess concentrations of melatonin can diminish the beneficial effects, or in some cases, can
even lead to deteriorated sperm attributes.
Melatonin antioxidants properties are not limited to potentially altering sperm
parametrics, other tissues of reproductive importance have been affected and warrant further
investigation to characterize the consequential effects of melatonin supplementation. Lemley et
al. (2013b) reported an increase in superoxide dismutase (SOD) from caruncular tissue in MEL
group compared to LUZ and CON groups. Brockus et al. (2016a) detected increased total
antioxidant capacity in maternal serum concentrations. Furthermore, using a bovine endometrial
in vitro model, melatonin was determined to increase SOD activity in comparison to its control,
while a group containing melatonin plus luzindole showed to have negated the melatonin effect
on SOD. In addition to tissues involved in reproduction, melatonin has also been shown to
decrease oxidative stress markers in non-reproductive tissues, such as decreased MDA levels and
lipid peroxidation in the liver of non-alcoholic fatty acid liver disease (NFLD) mice (Hatzis et
al., 2013).
1.9.4

Melatonin and Adipogenesis
The literature is still inconclusive on the exact mechanisms involved in adipose

metabolism. Current research demonstrates differential effects on melatonin and adipogenic and
24

lipogenic activity. Melatonin receptors have been identified in in vitro pre-adipocyte, brown and
adipose tissue cell lines and (Brydon et al., 2001) and in Siberian hamsters with more expressed
in BAT than WAT. Upon maturation of the pre-adipocyte cell line, melatonin supplementation
has been reported to inhibit GLUT4 and glucose uptake in white adipocytes (Brydon et al.,
2001). It was reported by Heo et al. (2019) that melatonin has a lipolytic effect towards adiposederived mesenchymal stem cells in humans. Lipolytic effects appear to be the case as reflected in
reduced adipose tissue in the epididymal and intra-abdominal and retroperitoneal area of rodents
administered melatonin (Puchalski et al., 1988; Rasmussen et al., 1999; Wolden-Hanson et al.,
2000). On the contrary, in BAT, there is evidence of increased proliferation in rodents
administered melatonin (Heldmaier et al., 1974). Since BAT is heavily involved in
thermogenesis, melatonin’s apparent involvement in BAT synthesis may be attributed to a
seasonal effect where thermogenesis is a necessity for hibernating animals. It is hypothesized
that there is a melatonin-mediated signaling pathway in which receptors in the suprachiasmatic
nucleus signal the regulation of catecholamine or adrenergic signals such as norepinephrine
(Song and Bartness, 2001; Thonberg et al., 2002) which are known to promote lipolysis. In
regard to BAT, there are still conflicting results on the outcome of synthesis; however, melatonin
is believed to upregulate BAT production by upregulating adipogenic genes that is required for
proliferation via activating cAMP pathways for protein kinase synthesis (Rosen et al., 1999;
Thonberg et al., 2002; Gray et al., 2006).
1.9.5

Melatonin and Circadian Rhythms
In mammals, many biological processes and molecular functions are regulated based

on circadian patterns. Factors such as daylight, feed availability and feed scheduling can alter
transcription factors involved in circadian regulation. Although the suprachiasmatic nucleus
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(SCN) of the hypothalamus is the primary regulator of circadian rhythmic actions in the body, it
has also been established that several peripheral tissues, including muscle appear to have their
own circadian regulatory system independent to that of the SCN (Yoo et al. 2004; McCarthy et
al., 2007). The molecular circadian clock pathway involves a cascade reaction, this is initiated by
the expression of transcription factors: aryl hydrocarbon receptor nuclear translocator-like
protein 1 (ARNTL1 or BMAL1) and Clock Circadian Regulator (CLOCK). This initiates the
subsequent expression of Period (PER1/2) and Cryptochrome (CRY1/2) genes, which present a
negative feedback loop and halt expression upstream. Additionally, secondary factors, including
Retinoic Acid-related orphan Receptor (ROR) which can create an oscillating activation of
ARNTL and is based upon the repressive activity of circadian factor Nuclear Receptor
Subfamily 1 Group D Member (NR1D1). This controlled transcription of primary circadian
factors, ARNTL and CLOCK can lead to several implications since ARNTL and CLOCK are
known to bind to over 2000 genomic targets (Koike et al., 2012). These include genes related to
myogenesis, adipogenesis and glucose homeostasis including the members of the Wnt family,
MyoD, PPARg and GLUT4 (Miller et al., 2007 Andrews et al., 2010; Dyar et al., 2013). Since
endogenous melatonin is heavily dependent on day light cycles, we associate melatonin with
circadian patterns. Melatonin has been established as a natural ligand for the ROR family
(Becker-Andre et al., 1994), a transcription family that has been established to influence
adiposity (Lau et al., 2008) Since melatonin has receptors in the SCN, myocytes and adipocytes
(Song and Bartness, 2001; Brydon et al., 2001; Ha et al., 2006) it can be hypothesized that
melatonin may play a hypothalamic-dependent and hypothalamic-independent influence on
skeletal muscle.
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1.10

Statement of the Problem
Cattle are the most significant livestock asset to agriculture and account for being the

third most consumed meat globally and the most consumed meat in the United States (USDAERS, 2019). The beef cattle industry can be segmented into three sectors of production: cow-calf
operations, stocker/backgrounding operations and cattle feeding operations. In the Southeast,
states such as Mississippi heavily rely on the production efficiency of cow-calf operations. The
two most significant factors that impact the profitability on cow-calf operations are calf crop
percentage (number of calves weaned relative to number of cows exposed) and weaning weight.
Therefore, high reproductive efficiency and neonatal growth and development are important
factors for profitability; conversely these factors are currently threatened in these operations.
External factors such as lower dam nutrient availability can negatively impact placental
efficiency, with reports in sheep having reduced uterine blood flow of 17-32% in underfed adults
(Chandler et al., 1985) and a reduced fetal weight by approximately 12% (Chandler et al., 1985).
The negative occurrences during the prenatal phase can consequently affect production in the
postnatal phase. Intrauterine growth restriction (IUGR) can consequently result in higher
mortality rates, decreased birth weights and lower average daily gain (Quiniou et. al., 2002).
Current information demonstrates the negative consequences of external factors on
placental function and developmental programming. However, there are still limited details in
molecular factors and pathways involved and how they influence phenotypes. In addition to
understanding the full extent of external factors on programming, there are even fewer studies
focusing on feasible therapeutics towards mitigating negative programming effects or enhancing
programming overall. Melatonin is one of few emerging therapeutics documented for use. From
the emerging data, melatonin has shown to improve uteroplacental hemodynamics in sheep
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(Lemley et al., 2012; 2013) and cattle (Lemley et al., 2012; 2013). These resulted in improved
characteristics such as increased fetal weights and post-natal performance and testicular
morphometrics (Brockus et al., 2016a; McCarty et al., 2018). However, most of the literature
involving the programming abilities of melatonin is limited to the prenatal phase. There is still a
need to determine whether melatonin can alter developmental plasticity during the postnatal
phase. This may provide a window of opportunity for producers to program their calves for
improved production and reproduction traits in the latter phase of production. Moreover,
melatonin’s involvement in circadian rhythms add another factor of interest since photoperiod
and seasonal effect are external factors that influence homeostasis and metabolism in the body,
including pathways involving myogenesis and adipogenesis. There is still a need for further
characterizing of melatonin when incorporating these external factors, and how they relate
towards altering the developmental trajectory. Further determination on the efficacy of melatonin
and the pathways that it is involved in can further improve management practices and
recommendations geared towards mitigating morbidities and enhancing performance.
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CHAPTER II
EFFECT OF MATERNAL NUTRIENT RESTRICTION, SIZE AND PERFUSION AREA ON
PLACENTOME CHARACTERISTICS AND TRANSCRIPTOMICS IN MID TO LATEGESTATING BEEF CATTLE
2.1

Abstract
The placenta is a transient organ that is essential for the exchange of nutrients, oxygen

and waste products between the dam and fetus; hence it is essential for fetal growth and
development. Efficiency of the placental exchange is critical and can be influenced by external
factors that lead to consequential manifestations during gestation. It is important to determine the
effect of adverse factors such as maternal nutrient restriction on placental function. Additionally,
there is still a need to determine whether placentome size variation is an external factor that can
influence placental efficiency. Therefore, the purpose of this study was to determine the effect of
(1) placentome size, perfusion and (2) maternal nutrient restriction on molecular, microscopic
and macroscopic features of bovine placentomes during late gestation. Pregnant cows (n = 6),
cows were equally divided into one of 2 treatments: CON (100% NRC) vs RES (60% of NRC)
from day 140 until slaughter at day 240 of gestation. Placentomes of different size classifications
(small, medium and large) were harvested for measuring placentome perfusion using
macroscopic imaging (IVIS). After imaging, a sub-classification within each placenta was made
based on either high perfusion or low perfusion. Microscopic imaging was performed to
determine blood vessel morphological parameters. Additionally, RNA extraction and sequencing
47

was performed on tissues in order to obtain differential expression levels of genes. Results
showed that placentome weights based on size classification were different (P < 0.0001).
However, macroscopic imaging showed that there was no difference in signal radiance (P =
0.42) or the perfusion rate of placentomes of different size classifications. Within placentomes,
macroscopic imaging showed heterogeneity, with two distinct areas of high and low perfusion
within each placentome. The region of high perfusion had increased blood vessel number, area
and perimeter (P < 0.005) compared to the low perfusion area. There were no differences in
microscopic characteristics based on size classification. Additionally, there was a dietary effect
on total perimeter (P < 0.05) with an increase in the RES group versus the CON group. Analysis
of differential expressed genes (DEG) showed 209 upregulations and 168 downregulations in the
RES group (cutoff P ≤ 0.0001). Gene Ontology (GO) analysis showed that enriched terms of
downregulated genes were involved in angiogenesis, blood vessel development, blood
circulation and mesenchymal stem cell development, whereas enriched terms of upregulated
genes were involved with translation, organophosphate synthesis and ribosomal function. There
were no differences in DEG analysis in regard to placentome vascularity and a negligible
difference in regard to placentome size with only one differentially expressed gene throughout
entire placental profile observed (P ≤ 0.05). The lack of macroscopic, microscopic and
transcriptomic differences in regard to placentome size strongly suggest that there is uniform
placental function among individual placentomes. Therefore size is not a critical factor when
sampling placentomes. In regard to perfusion, heterogeneity exists within each placentome as
denotes by macroscopic and microscopic differences observed. Therefore careful consistency of
sample collection region should be considered for microscopic components. However, this
should apply if genomic/transcriptomic analyses is being conducted. Furthermore, under
48

maternal dietary constraint where downregulation of developmental factors occur, a
compensatory mechanism of increased perimeter may be attributed to the placenta signaling for
subsequent upregulation of factors to optimize nutrient transport and mitigate cell proliferation
and differentiation.
2.2

Introduction
The prenatal phase of development is reliant on a functioning placenta. External factors

can directly impact the placenta which can result in fetal programming. This is especially
important around mid-to late gestation when vascular development is at its greatest and the fetus
relies on it the most for nutrient uptake. In bovine species, the placenta comprises a collection of
singular tissues from trophoblast origin that are made up of vascular tissue and blood vessels.
These are known as placentomes; a single animal can have approximately 60-120 placentomes.
Placentomes can differ in size from ipsilateral to contralateral uterine horn and as gestation
progresses (Schafer et al., 2000). Placentome function is heavily regulated by molecular factors,
including vascular endothelial growth factor (VEGF) which promotes the growth of blood
vessels (Carmeliet et al., 1996), and endothelial nitric oxide synthase (eNOS), which synthesizes
NO needed for vasodilation (Arroyo et al., 2010).
Detrimental environmental effects can render a state of placental insufficiency, which is
the incapacity for the placenta to effectively transfer the appropriate level of nutrients, oxygen
and waste products between dam and fetus (Kusinski et al., 2012). Environmental stressors have
the potential to negatively impact factors such as blood flow and nutrient uptake, which can lead
to consequential effects, such as placental insufficiency and fetal growth restriction (Arroyo et
al., 2010). Altering the maternal nutrient diet is widely documented; maternal undernutrition and
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overnutrition models have shown to alter umbilical blood flow and arterial indices of resistance,
which is believed to be responsible for growth restrictions in some livestock offspring (Lekatz et
al. 2010b, Lemley et al. 2012, Lekatz 2013). The extent of these restrictions are reflected in
humans with a higher prevalence of health issues, including diabetes, hypertension and heart
disease (Barker and Osmond, 1988; Barker et al. 1990; Osmond et al., 2007)
Other than general morphometrics, there is limited knowledge on the molecular and
cellular variation of bovine placentomes during gestation. Previous studies have indicated that
variations in angiogenic factors can reflect differences in placentome morphometrics when
comparing Bos taurus versus Bos indicus cattle (Lemley et al., 2018). Conversely, one study by
Picking et al. (2020) utilized heifers in collecting a single placentome from four various regions
on the antimesometrial side of the gravid uterine horn: central to the amnion, over the
chorioallantois immediately adjacent to the amnion, the tip of the gravid uterine horn, and the tip
of the contralateral uterine horn. Placentomes collected from different locations had size
variations. However, there were no effects of location on angiogenic factors, nutrient transporters
as well as certain genes involved in hormonal mechanisms. These factors can potentially affect
the rate of blood flow, which hereby affects the concentration of substances including oxygen,
glucose and amino acids. Additionally, different breeds can experience altered angiogenic
expression and placentome morphometrics as reported by Lemley et al. (2018) in a comparison
between Bos taurus versus Bos indicus cattle.
In order to further understand the mechanisms involved in placental blood flow, it is
important to determine the perfusion rates and gene expression levels among varying
placentomes and whether factors including placentome size and vascular region alter these
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rates/levels. Determination of this would be useful for future reference when sampling and
analyzing placentome tissues. Recently, Picking et al. (2020) developed a non-lethal surgical
procedure that allows for harvesting a single placentome from a ewe; therefore providing the
opportunity for repeated measurements. However, it is important to determine the magnitude of
variability when collecting from only one placentome per animal.
With these factors taken into consideration, the objectives of this study were to (1) evaluate
placentome perfusion and gene expression in placentomes of different sizes and within different
vascular regions and (2) determine the effect of maternal nutrient restriction on placentome
perfusion and gene expression.
2.3
2.3.1

Materials and Methods
Animal Management and Treatments
Animal care and use was approved by the Mississippi State University Institutional

Animal Care and Use Committee (IACUC). Commercial cattle were all bred via natural service
by a single sire. Pregnancy was confirmed at 30-days post-breeding via trans-rectal
ultrasonography. After confirmation of pregnancy (n = 6), cows were equally divided into one of
2 treatments: CON (fed 100% of nutritional requirements of gestating cattle) vs RES (fed 60%
of Nutritional Requirements of gestating cattle) from 140 to 240 days of gestation. The dams
were slaughtered on day 240 of gestation. After successful removal of the fetal calf, six
placentomes were excised from the uterus. Two large placentomes nearest to the entry of the
umbilical cord, 2 medium placentomes and 2 small placentomes were next excised moving
further from the umbilical cord but staying within the gravid horn. The 6 placentomes were
submerged in PBS and immediately transported back to the department of animal and dairy
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science (Mississippi State, MS). The placentomes were weighed and equally divided into
positive and negative controls for imaging
2.3.2

Placentome Perfusion and Macroscopic Imaging
Placentome perfusion was conducted as previously described by Lemley et al. (2018).

The cotyledonary artery was dissected and catheterized using a 20-g by 2-inch Exel Safelet Cath
(Exelint International, Los Angeles, CA). This was followed by the perfusion of approximately
20 to 30 mL of PBS through the cotyledonary artery and the determination of PBS exiting the
cotyledonary vein and cleared of blood. Half of the placentomes (1 large, 1 medium, and 1
small) were immediately imaged as negative controls. The other half of the placentomes (1 large,
1 medium, and 1 small) were perfused with a sufficient volume of 200 µg/mL Concanavalin A,
Alexa Fluor 647 conjugate (ThermoFisher Scientific, Waltham, MA) in order to ensure drainage
of the fluorophore through the cotyledonary vein. After perfusion, the cotyledonary artery and
cotyledonary vein were ligated with silk suture. Placentomes (both negative and positive
controls) were immediately imaged using an in vivo imaging system (IVIS) Lumina XRMS
series III (PerkinElmer, Waltham, MA). The radiance signal (photon/s/cm2 /sr) from each
sample was obtained from the IVIS system and assessment of the radiance signal per gram was
performed to correct for any differences in total placentome weight.
Following macroscopic blood vessel density imaging via the IVIS, an area of high perfusion and
an area of low perfusion were selected for further tissue processing within each placentome
(figure 2.1). Therefore, two areas of interest were selected for tissue processing within each
positive control placentome. A 1- by 1-cm placentome section was collected from an area of high
perfusion and an area of low perfusion (as determined by IVIS images) and placed in optimal
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cutting temperature (OCT) tissue embedding media (Fisher Scientific, Pittsburgh, PA). For RNA
sequencing, the cotyledon was separated from the caruncle and cotyledonary tissue from an area
of high perfusion and an area of low perfusion were placed in cryotubes and snap-frozen in
liquid nitrogen and stored at -80 degrees Celsius.
2.3.3

Placentome Microscopic Imaging
Placentomes perfused with 200 µg/mL concanavalin A, Alexa Fluor 647 conjugate

through the cotyledonary artery and embedded in OCT molds were sectioned into four 10-μm
cryosections using a CRYOSTAR NX50 (Thermo Scientific, Waltham, MA) and positioned on
positively charged microscope slides. In order to evaluate microscopic blood vessels (figure 2.1 )
slides were blocked for 30 min with 10% goat serum in PBS with the addition of 0.2% Tween20. In order to counterstain the caruncular epithelium and fetal villi, slides were incubated with
10-μg/mL Fluorescein-labeled Griffonia Simplicifolia Lectin I (FL-1101; Vector Laboratories,
Burlingame, CA). Lastly, tissue sections were treated with Fluoroshield mounting medium with
DAPI (ab104139; Abcam) for nuclear staining. Images were captured using an EVOS
microscope (AMAFD1000; Life Technologies, Carlsbad, CA) with 10× magnification. At least
10 representative photomicrographs were captured per animal. Images captured with the EVOS
CY5 light cube (Alexa Fluor 647) were then analyzed using ImageJ (https://imagej.nih.gov/
ij/download.html). Total capillary number per tissue area (vessel number/mm2), percent capillary
area (%/ mm2 ), average capillary size (μm2 ), and average capillary perimeter per tissue area
(mm/mm2 or mm−1) were recorded.
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2.3.4

Placentome RNA Extraction and NanoDrop One Analysis
Total RNA was extracted from placentome samples using the RNeasy

extraction kit (QIAGEN, Hilden, Germany) according to the protocol issued. Extracted total
RNA was quantified using a NanoDrop One spectrophotometer (Thermo Scientific, Waltham,
MA). The manufacturer’s minimum requirements for each sample sequenced were as follows: a
total RNA amount of ≥ 1 μg, a total volume of ≥ 20μL, an RNA integrity number (RIN) of ≥ 6.8,
a total concentration of ≥ 20ng/μL, and a 260/280-nm ratio >2.0. Samples were stored in 2.0 mL
tubes at −80 °C until they were shipped on dry ice for sequencing (Novogene Corporation Inc.,
Sacramento, CA).
2.3.5

RNA sequencing
RNA sequencing was conducted by the manufacturer’s designated protocol (Novogene

Corporation Inc., Sacramento, CA). The amount of 1 μg of RNA was utilized as input material.
The NEBNext®Ultra™ RNA library prep kit for Illumina® (NEB, USA) was utilized according
to the manufacturer’s recommendations to generate sequence libraries. Index codes were added
to characterize sequences to each sample. cDNA was synthesized by random hexamer primer
and M-MuLV reverse transcriptase/RNase H (first strand); along with DNA Polymerase I and
RNase H (second strand). cDNA fragments of 150~200bp in length were selected, after which
PCR was performed using phusion high-fidelity DNA polymerase, universal PCR primers, and
index (X) primer. PCR products were purified and library quality was evaluated. Index-coded
samples were clustered using a PE cluster kit cBot-HS (Illumina) and library preparations were
sequenced on an Illumina platform to yield 125 bp/150 bp paired-end reads.
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2.3.6

Statistical Analysis and Bioinformatics
Statistics for body weights, placentome size, IVIS, and microscopic blood vessel density

were analyzed as a completely randomized design using the mixed procedure in Statistical
Analysis Software (SAS) version 9.4 (SAS Institute, Cary, NC, USA). Fixed effects included
size, perfusion and diet. Fixed effects of diet were not included in graphs and figures in P > 0.10.
Least square means and standard error of the means are reported. The level of significance was
determined at P ≤ 0.05. For RNA seq data, raw sequence reads were processed using the fastq
format. All the downstream analyses were based on clean reads with high quality. Reference
genome and gene model annotation files were downloaded from the genome website directly:
(https://ftp.ncbi.nlm.nih.gov/genomes/Bos_taurus/). For mapping next-generation sequencing
reads, HISAT2 was used. Gene expression levels were quantified firstly by utilizing the readcount summarization program, feature counts system v1.5.0-p3 (Liao et al., 2013), after which,
the fragment per kilobase of transcript (FPKM) of each gene was calculated. Differential
expression analysis between groups was performed using the DESeq2 R package (1.14.1). In
order to control the false discovery rate (FDR), the procedure of Benjamini and Hochberg (1995)
was used P-values. Genes with an adjusted P-value of < 0.05 were assigned as differentially
expressed. The gene ontology (GO) enrichment analysis was conducted using clusterprofiler R
package, this also corrected gene length bias. Gene ontology terms with a corrected P-value of <
0.05 were considered significantly enriched by differentially expressed genes.
2.4
2.4.1

Results
Weight, Placentome Size and Perfusion
There was a dietary effect (P < 0.01) for maternal body weight observed in RES dams

(600.15 ± 18.69 kg) versus CON dams (722.45 ± 18.69 kg). There was no dietary effect (P <
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0.66) on fetal weight in RES dams (19.10 ± 1.76 kg) versus CON (17.92 ± 1.76 kg). Figure 2.2
depicts placentome weight and signal radiance (perfusion rate). Placentome weight was different
(P < 0.0001) between large, medium, and small placentomes (figure 2.2A). Macroscopic blood
vessel density of all collected and perfused placentomes is illustrated in figure 2.2B. Despite
different size categories, macroscopic blood vessel density as detected by the IVIS, was not
different (P = 0.42) between large, medium, and small placentomes. Microscopic blood vessel
number and density was altered within placentomes based on areas of high and low perfusion
detection using the IVIS macroscopic blood vessel technique (figure 2.1). Figure 2.3 displays the
main effects on blood vessel microscopic characteristics (main effect of diet not reported if P >
0.10). Blood vessel number was not different (P = 0.46) between large, medium, and small
placentomes. The number of blood vessels increased (P = 0.001) in areas of high perfusion
compared with low perfusion. The average size of blood vessels was not different (P < 0.15)
between or within placentomes. The percent area of blood vessels was not different (P = 0.91)
between large, medium, and small placentomes. The percent area of blood vessels was increased
(P = 0.005) in areas of high perfusion compared with low perfusion. Similarly, the total surface
area of blood vessels was not different between large, medium, and small placentomes.
However, the total surface area of blood vessels was increased (P = 0.001) in areas of high
perfusion versus low perfusion. Analysis of differentially expressed genes (DEG) demonstrated
that among placentome sizes, there was an upregulation in SERPINA14 and CLCNKA in large
versus small placentomes (P < 0.05). This was corroborated by GO analysis, which showed that
of the 2021 GO terms, 6 terms involving peptidase and endopeptidase activity were significantly
enriched (P < 0.04) and were exclusive to altered expression of SERPINA14. Otherwise, there

56

were no differences in gene expression among placentome sizes. Additionally, no differences in
expressions were observed between areas of high versus low perfusion.
2.4.2

Maternal Nutritional Plane on Placenta
There was a dietary effect on average placentome weight in dams (P = 0.03). The

average weight of an individual placentome from the RES group was greater at 95.21 ± 6.56 g
compared to the CON group at 72.51 ± 6.56 g. However, the perfusion rate per weight of the
placentome was not different (P < 0.22). Results from the microscopic analysis demonstrated
that nutrient plane had no effect on blood vessel count, average size and percent area (P > 0.19).
However, in Figure 2.3D, an increase in total blood vessel perimeter was observed (P < 0.05) in
the RES group (31.08 ± 1.64 mm-1) compared to the CON group (25.96 ± 1.64 mm-1).
Analysis of differentially expressed genes (DEG) showed a dietary effect on placentome
gene expression. In the RES group, 209 gene upregulations and 168 downregulations were
identified within placentome tissue at an adjusted P-value cutoff at P ≤ 0.0001 (Table A1 and
Table A2) The nutrient-restricted diet had a transcript abundance of eight uncategorized genes
containing unknown RNA sequences. Gene Ontology analysis (figure 2.4) showed that among
the enriched GO terms in downregulated genes, biological processes (BP) involved were
development of vascular, cardiovascular, circulatory systems as well as mesenchymal stem cell
development, cell components (CC) involved included the extracellular matrix, and molecular
functions (MF) involved receptor and binding activity. Of the GO terms enriched in upregulated
genes (Figure 2.5), biological processes mostly involved were in translation and metabolism of
peptides, purines, nucleosides and organophosphates, cell components related to the ribosome
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and mitochondria were involved and molecular function involved mostly protein and RNA
binding.
2.5

Discussion
Mid to late gestation is the critical time period where vascularization of blood vessels is

maximized in order to facilitate the nutrient and oxygen demand of the fetus. In sheep, there is
uniformity of vascularization and gene expression in individual placentomes regardless of
placentome shape (Vonnahme et al., 2008). However, in the case of bovine placentomes, there is
a paucity of literature detailing whether placentome morphometrics affect microscopic
characteristics such as capillary size and density. Additionally, information involving whether
these morphometrics and characteristics affect blood flow is virtually non-existent. This study
utilized placentomes of different size classifications in order to determine these effects. The
placentome size coincided with different weights. A novel technique developed in our lab
demonstrated the perfusion rate among different placentome sizes. The IVIS system detected
areas of high perfusion and low perfusion within each placenta. Following this observation, a
classification based on high and low perfusion was established. Microscopic imaging verified
that characteristics such as blood vessel number, vessel area and perimeter were higher in the
high perfusion area versus than in the low perfusion area (figure 2.3). Interestingly, despite
differences in size of each placenta, figure 2.2 shows that with the varying placentome sizes,
there was no difference in perfusion rate among placentomes. This demonstrates that each
placentome uniformly perfused blood for an even distribution of blood flow throughout the
entire placenta regardless of size. This is supported with microscopic imaging, which showed no
differences in the blood vessel number, size, area and total perimeter among placentome sizes. In
relation to maternal diet, placentome microscopic characteristics were similar except for an
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increase of the total perimeter in the RES group versus the CON group. The rate of blood flow is
directly related to the blood vessel cross-sectional area since a larger blood vessel can facilitate a
higher amount of blood within the same time compared to a smaller vessel. Since blood from a
vessel with a larger diameter is able to travel faster than a vessel with a smaller diameter, blood
vessel resistance is inversely related to the diameter of that vessel: more resistance from blood
resistance results in a reduced blood flow rate. However, capillary perimeter is involved with
nutrient transport as a longer vessel aids more outreach towards target tissue and hence more
efficiency in nutrients reaching their targeted destination. It appears as a result of lower available
nutrients, placentomes are compensating with extending vessels for the fetus to uptake as much
available nutrients as possible. Although this compensatory effect was not as extreme when
compared to results from Lemley et al. (2018) where heifers subjected to a similar restriction
from day 50 to 175 of gestation experienced increased capillary area, perimeter and percent area.
This may be attributed to utilizing heifers instead of cows. Heifers are less efficient at nutrient
partitioning during pregnancy because nutrients are still geared towards growth and development
of tissues within that heifer compared to that of fully mature cows.
In order to determine the levels of differential gene expression in placentomes from
restricted dams, a bioinformatics analysis on extracted mRNA was performed. In terms of
placentome size, genes differentially expressed were negligible. Only two genes involving
endopeptidase inhibition were differentially expressed between the large and small placentomes;
otherwise there were no differences in placental transcriptomics. This further strengthens the
notion of uniformity based on size within bovine placentomes. Rather than collecting several
placentomes, a single placentome regardless of size within an animal has a uniform characteristic
and can be sampled for analyses involving transcriptomic markers of placental function and
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efficiency. This represents an important finding, as results depict that for the purposes of
collecting bovine placentome samples, an individual placentome depicts an accurate and precise
representation of the entire placenta as it relates to blood vessel density, capillary parameters,
and transcript abundance. In the case of perfusion area within a placentome, results from IVIS
imaging (figure 2.1) as well as microscopic imaging (figure 2.3) show that within each
placentome, there is a region of higher perfusion/ vascularity compared to another region which
is of lower perfusion/vascularity. This heterogeneous nature can play an impact when utilizing
microscopic imaging. Therefore, consistently when sampling from a particular region should be
considered for microscopic imaging. On the other hand, transcriptomic results showed no altered
gene expression in regards to the perfusion area or the level of vascularity. Therefore, for
analyses focusing on genomics/transcriptomics, the perfusion area or level of vascularity is not a
critical factor for altering results due to the uniformed gene expression pattern throughout
regions of different perfusion levels.
Although there was not a dietary effect on blood vessel diameter, area and number, our
results (Figure 2.4) demonstrate a downregulation in a vast number of genes involved in
angiogenesis, connective tissue development, circulatory system development and function.
There appears to be a compensatory effect occurring. Additionally, genes involving
mesenchymal stem cell development and differentiation limit developmental potential. Factors
including bone morphogenic proteins (BMPs), growth factors (families of Wnt, IGF, and FGF)
are critical for signaling pathways during the prenatal periods. Downregulation of genes involved
in nephron development, skeletal development and cytokine production were observed in the
RES group versus the CON group. Previous studies reported on decreased nephron numbers
were observed in offspring from nutrient restricted dams (Hinchliffe et al., 1992; Langley-Evans
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et al., 1999; Whorwood et al., 2001). The skeletal and renal system play key roles in homeostasis
of minerals including sodium, potassium, calcium and phosphorus. An insult in these systems
could lead to onset issues involving fluid and ion imbalance. In addition to downregulation of
genes involved in skeletal system development, there was a downregulation of several genes
involved in immune response in RES placentomes, including cytokine production and toll-like
receptor pathways. A downregulation in these processes may have negative consequences on
immune function in later life due to potential alterations in cell processes involving
hematopoiesis and leukocyte proliferation, differentiation and alterations in signal transduction
pathways and cellular response to organic compounds and endogenous stimuli. In the case of
pigs, a maternal restricted diet resulted in decreased leukocyte and toll-like receptor numbers in
offspring (Hu et al. 2015; Baek et al., 2019).
Inversely, there was an upregulation in genes related to translation, metabolism of
nucleosides, ribosomal function, amide and protein synthesis in RES placentomes (figure 2.5).
Protein translation and ribosomal biogenesis are also actively involved in cell proliferation,
differentiation and development. It is likely that these factors are compensating for
downregulated developmental factors, and as a result yield no differences in blood vessel size,
area and number. Furthermore, these upregulated factors are believed to account for the
compensatory effect yielded in increased perimeter in the RES group. It appears that an increase
in translation and ribosomal genes serve as a signal to placental tissues for maximizing nutrient
prioritization to the fetus under a compromised diet during pregnancy. Further investigation
warrants pathway analysis and determination of protein activation.
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Figure 2.1

Two medium size placentomes with circled areas of high blood perfusion versus low blood perfusion (Panel A). These
two images show heterogeneous areas of blood perfusion within a single placentome. Following IVIS imaging
placentomes underwent cryopreservation in specific areas of high versus low perfusion (Panel A). Representative
immunofluorescence micrograph images of heifer placentomes at day 240 of gestation. Panel B depicts a micrograph
image taken from an area of high blood perfusion and Panel C depicts a micrograph image taken from an area of low
blood perfusion. Cotyledonary arteries were perfused with Concanavalin A Alexa Fluor 647 conjugate (orange) prior to
fixation (Panel B and C). Cryosectioned placentomes were stained for caruncular and chorionic epithelium (green;
FITC), and nuclei (blue, DAPI).
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Figure 2.2

Placentome weights at day 240 of gestation and fluorescent signal intensity relative to placentome weights. Superscripts
denote significance for placentome weights (P < 0.001).
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Figure 2.3

Harvested placentomes at day 240 of gestation evaluating blood vessel number (A), average vessel size (B), percent
vessel area (C), and total vessel perimeter (D). In placentomes based on size and perfusion region. Superscripts denote
significance for vessel number (P = 0.001), percent vessel area (P < 0.005), and total vessel perimeter (P = 0.001).
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Figure 2.4

Hierarchical representation of significantly enriched gene ontology (GO) terms of downregulated genes (biological
processes, cellular components, and molecular function) in placentomes from the RES group.
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Figure 2.5

Hierarchical representation of significantly enriched gene ontology (GO) terms of upregulated genes (biological
processes, cellular components, and molecular function) in placentomes from the RES group.
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CHAPTER III
EFFECT OF CHRONIC MELATONIN SUPPLEMENTATION DURING MID- TO LATEGESTATION ON MOLECULAR PERFORMANCE AND CIRCADIAN FACTORS
IN BEEF CATTLE LOIN MUSCLE
3.1

Abstract
Environmental changes during gestation can affect fetal development which can

potentially continue after birth and through adulthood. Factors including maternal nutrient
restriction are shown to have negative effects on fetal development. Ongoing research in
therapeutics, including melatonin, are promising for their potential to ameliorate compromised
pregnancies and enhance uterine environment for the fetus. The purpose of this study was to
analyze the effects of maternal nutrient restriction and dietary melatonin supplementation on
fetal morphometrics and loin muscle growth factors. Two feeding trials consisting of a total of
Fifty-four pregnant Brangus heifers were utilized in a 2 x 2 factorial study over a two-year
period. The first trial utilized twenty-nine spring-calving heifers in fall 2019, while the second
trial utilized twenty-five fall-calving heifers. There were 2 planes of nutrition, ADQ (100% NRC
feed requirements) or RES (60% NRC feed requirements) and 2 treatments of control feed
(CON) or melatonin-supplemented feed (MEL). Heifers received dietary treatments from 160 to
240 d of gestation. At day 240, Cesarean sections were performed and fetal morphometric data
were collected. Fetal longissimus dorsi (LM) samples were snap frozen and stored at -80◦C for
mRNA isolation and qPCR. In trial 1, fetal morphometrics were not different among treatments
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(P > 0.19) a decrease in ARNTL expression was observed in RES and MEL groups (P = 0.0003).
A diet x treatment interaction was observed in growth-related transcription factor IGF1R (P =
0.042). Expression of MYF6 decreased in MEL groups (P = 0.020) while a diet effect showed a
decrease in MYOD1 expression in RES groups (P = 0.001). In trial 2, semitendinosus weight
relative to fetal weight experienced a nutrient x treatment interaction (P = 0.007). A nutrient x
treatment and a nutrient x time interaction were observed in MYF6 with increased expression (P
= 0.006) in the RES-PM group compared to other groups and a decreased expression in the
CON-AM group when compared to others (P = 0.001). A nutrient x treatment x time interaction
observed in IGF1 with the ADQ-MEL-AM group having increased expression versus all other
groups (P = 0.004). Results showed a differential expression of melatonin and restricted diet. A
seasonal effect in which melatonin and a lower energy diet are resulting in tissue prioritization
for energy and thermogenic metabolism.
3.2

Introduction
Skeletal muscle is one of the most metabolically active organs in the body and plays a

fundamental role in the overall physiology of an organism. Skeletal muscle consists of more than
600 individual muscles as well as nerves, blood vessels, muscle fibers, and adipose tissue. In
addition to providing structural integrity, locomotion, and thermogenesis, skeletal muscle also
facilitates glucose, glycogen, amino acid, and lipid metabolism. These abilities make for skeletal
muscle’s versatility as it is able to serve as a reservoir for energy and nutrient metabolism. It is
common knowledge that many of these metabolic activities within muscle tissue are regulated by
the typical 24-hour circadian pattern. This rhythm is primarily regulated by the suprachiasmatic
nucleus (SCN) of the hypothalamus. However, it is now established that circadian oscillations
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within periphery tissues can be independent of the SCN, including liver, lung and skeletal muscle
tissue (Yoo et al. 2004; McCarthy et al. 2007).
The circadian clock of the skeletal muscle is regulated through a network of positive and
negative transcriptional and translational factors (Sangoram et al., 1998; Bass, 2010). These
include ARNTL (Aryl hydrocarbon receptor nuclear translocator-like protein) otherwise known
as BMAL1 (Brain and Muscle Arnt-like 1) and CLOCK (Circadian Locomotor Output Cycles
Kaput) which form a heterodimer that binds to E-box sequences which signals transcription
activation of its negative regulators: PER (Period 1, 2) and CRY (Cryptochrome) 1, 2. PER and
CRY will bind to CLOCK-BMAL1 and disrupt transcription. Additionally, Rev-erb alpha and beta
can directly repress BMAL1. It will bind to a circadian sequence known as RORE (Retinoic
Acid-related orphan receptor) which activates ROR-alpha to create an oscillating regulation of
BMAL1 expression.
The implications of altered circadian rhythms have shown their relevance in muscle
metabolism and functions. Oscillating circadian rhythms are shown to play an important role in
regulating as Myogenic Differentiation 1 (MyoD1), a key transcription factor in early myoblast
differentiation. Additionally, it regulates Wingless-related integration site (Wnt), a factor that
promotes embryonic development of skeletal muscle lineage and adult satellite cell function (Le
Grand et al., 2009; Bentzinger et al., 2013). Studies ablating BMAL1 and CLOCK shows
reduction in MyoD1and Wnt expression (Miller et al., 2007 Andrews et al., 2010). Similarities
were reported in ablation of ROR and PER 1 and 2 in mice (Zheng et al., 1999). They are based
on a circadian pattern set up by BMAL1 and CLOCK. Lipton et al. (2015) has also found that
BMAL1 is involved in promoting protein synthesis via the Akt/mTOR pathway. Hodge et al.
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(2015) reports on differences in gene expressions involved in metabolism and myofiber type due
to irregular patterns in Bmal1 using KO models. The authors reported on KO models having an
experienced shift towards increased fast to slow fiber types and more oxidative fibers versus the
control. This suggests that glycogenic pathways towards storage are impeded. Dysregulation of
circadian rhythms can impede muscle development, nutrient transporter abundance and
metabolic function such as imbalanced insulin-dependent glucose uptake and lower GLUT4
levels for uptake, as observed in Cre-lox muscle knockout models (Dyar et al., 2013).
In regard to fat metabolism, Hodge et al. (2015) also added that irregularities are shifting
towards that of lipid oxidation in skeletal muscle with alterations in beta-oxidation genes,
including PPARg. Similar irregularities have been reported towards circadian irregularities and
fatty acid metabolism in skeletal muscle. Wefers et al. (2018) reported on short-term circadian
misalignment affecting fatty acid expressions from the PPAR family, along with molecular
pathways that result in the promotion of insulin resistance in humans.
These dysregulations should therefore be further explored in livestock animals, as
circadian patterns may heavily influence production of economically important tissues.
Alterations in circadian patterns and timing of feed availability have been documented to affect
milk components including fat, protein and urea nitrogen (Salfer and Havatine, 2020).
Additionally, since melatonin secretions are based on photoperiod, and play a role in mediating
season effects, it is important to determine the roles of melatonin and feed restriction on
circadian genes and their subsequent gene targets. These target genes have the potential to reduce
muscle numbers and weights, and affect meat quality such as color, water-holding capacity and
marbling in livestock. Additionally, there is even scarcer research available on how circadian
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rhythms alter molecular pathways in gestating animals and how these patterns can alter fetal
programming. Utilizing livestock models can improve on research geared towards the short and
long-term implications of irregular circadian patterns on livestock production and also serve as a
precursor model towards human developmental programming research.
3.3
3.3.1

Materials and Methods
Animal Care and Treatment
Animal care and use was approved by the Mississippi State University Institutional

Animal Care and Use Committee (IACUC #17-709). This study was conducted over a two-year
period utilizing a total of fifty-four Brangus heifers in two separate trials. In Fall 2019 (Trial 1),
twenty-nine spring-calving Brangus heifers at day 160 of gestation were assigned to 1 of 4
groups: an adequate diet (ADQ-CON; 100% NRC; n = 7), a nutrient-restricted diet (RES-CON;
60% NRC; n = 7), an adequate diet supplemented with 20 mg of melatonin (ADQ-MEL; n = 7),
and a nutrient-restricted diet supplemented with 20 mg of melatonin (RES-MEL; n = 8). These
animals were in these treatments for 80 days until Cesarean sections at day 240 of gestation. The
trial was duplicated in summer 2020 (Trial 2), using twenty-five fall-calving Brangus heifers
under the same allotted treatments: ADQ-CON (n = 6), RES-CON (n = 6), ADQ-MEL (n = 6),
and RES-MEL (n = 7) and for the same duration (80 days).
For the melatonin treatments, melatonin powder (#14427; Cayman Chemical Company,
Ann Arbor, MI) was dissolved in absolute ethanol (100% ethanol) at a final concentration of 10
mg/mL. A total of 2 mL was top-dressed in 2 lb grain (vitamin mix). The control groups (ADQCON; RES-CON) received a top-dressing of 2mL containing only absolute ethanol. Diets were
adjusted weekly based on body weights. Heifers were fed daily at 0900h using the Calan feeding
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system ©. The treatment was provided first and after the heifers finished their portion
(approximately 15 minutes later). Control diets were fed at a total of 2.4% of BW/day with a
target gain of 1.0 kg/d. The restricted diet received 60% their calculated control diet. Heifers
received a TMR (71.65 % DM, and 11.27 % protein, 3.65 % fat, 4.66 % crude fiber, and 38.95 %
ADF on DM basis) as well as chopped hay (90.5 % DM, and 7.1 % protein, 73 % NDF, 42.4 %
ADF on DM basis). All heifers fully consumed their feed by approximately 1045 h. At day 240
of gestation, Cesarean sections were performed either at 0400 h in the morning (AM) or 1300 h
in the afternoon. This created an overall 2 x 2 x 2 factorial design with the main effects of diet,
treatment and time.
3.3.2

Blood Analysis
Fetal blood analysis was conducted by Contreras-Correa (2021). Melatonin assays were

performed using a melatonin ELISA kit (TECAN, Morrisville, NC, USA) with an analytical
sensitivity of 1.6 pg/mL and inter- and intra assay of 11.4 and 19.3 %.
3.3.3

Fetal Muscle Morphometrics
After each surgery, fetal necropsies were immediately performed which the left and right

loin muscle were dissected from the fetus to determine weight, length, and circumference at the
midline. After which, samples were portioned into cryotubes, snap-frozen in liquid nitrogen and
stored at -80 degrees Celsius.
3.3.4

RNA Extraction and Gene Expression
Loin muscle samples were processed for RNA extraction. Approximately 200 mg of loin

muscle was suspended in Qiazol ™ Lysis buffer and isolated using the protocol from the
miRNeasy mini kit (QIAGEN, Germantown, MD, USA). Concentrations of RNA were measured
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using a Nanodrop ™ One Microvolume UV-Vis Spectrophotometer (Thermo Fisher Scientific,
Auburn, AL, USA). Loin muscle samples were diluted to a standard of 100 ng/µl. A total of 10
µl of RNA was combined with 10 µl of PCR reaction cocktail prepared from a High-Capacity
cDNA Reverse Transcription Kit (Thermo Fisher Scientific, Auburn, AL, USA) for generation
of cDNA. Aliquots of cDNA were made at a ratio of 1:20. Expression of circadian,
metabolomics, adipogenic and myogenic genes was analyzed utilizing TaqMan ® Assays
depicted in Table 3.1 (Thermo Fisher Scientific, Auburn, AL, USA). Quantification in a 96-well
plate was used at a final volume of 10 µl (each well contained 1 µl cDNA and 9 µl of TaqMan ®
reagent cocktail) with 4 replicates for each sample-gene analysis. Plates were read using a
QuantStudio™ 3 Real-Time PCR system (Applied Biosystems, Foster City, CA, USA). Raw
data was analyzed using the 2-ΔΔCt method. The geometric mean of Beta Actin and RPS9 was
used as a reference to normalize all the selected gene expression data.
3.3.5

Statistical Analysis
Data were analyzed using the mixed procedure of SAS version 9. 4 (SAS Institute, Cary,

NC, USA). Gene expression data were analyzed as a 2 x 2 x 2 design, where the main (fixed)
effects were diet, treatment and time of C-section. Fetal sex and day of gestation were included
in the model as covariates. All interactions were removed when P ≥ 0.10. Covariates were
removed when P > 0.10. Least square means and standard error of the means are reported.
Statistical significance was declared at P < 0.05 while a tendency was declared at 0.05 < P <
0.10.
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3.4
3.4.1

Results
Blood Analysis
Blood measurements were taken at day 240 of gestation (Adapted from Contreras-Correa,

2021). In fall 2019 demonstrated that there was an increase in melatonin concentrations in
fetuses from MEL dams compared to CON dams at 83.59±20.68 versus 22.94±8.76 pg/mL.
Similarly, in fetuses from RES dams, an increase in melatonin levels were observed (P = 0.0417)
compared to CON dams at 72.91±22.09 versus 34.37±9.73 pg/mL. In summer 2020, there was
an increase in melatonin levels in fetuses from MEL dams (P = 0.0007) compared to CON dams
at 61.78±14.90 versus 5.43±3.10 pg/mL.
3.4.2

Fetal Muscle Morphometric Measurements
Fetal muscle measurements taken at day 240 of gestation are displayed in table 3.2 for the

fall 2019 trial and table 3.3 for the summer 2020 trial (adapted from Contreras-Correa, 2021).
Morphometrics from fall 2019 showed that fetal weight was reduced in the restricted groups
versus adequate-fed (P = 0.0087). However, there were no differences in main effects in regard
to muscle measurements. Morphometrics from summer 2020 showed a nutrient x treatment
interaction observed fetal weights (P= 0.029). Moreover a similar nutrient x treatment observed
in the right and left loin muscle weights where the RES-CON and ADQ-MEL groups had
decreased weights compared to the ADQ-CON and RES-MEL groups. Semitendinosus muscle
experienced an increase in weight relative to fetal weight in the RES-CON group and the ADQMEL group compared to the ADQ-CON group.
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3.4.3

Fetal Loin Muscle Gene Expression
Gene expression results from fetal loin muscle samples obtained during the fall 2019 trial

are shown (figures 3.1 - 3.4). For circadian genes (Figure 3.1), there was a tendency for
decreased expression in CRY1 (P = 0.053) and a tendency for decreased expression in CLOCK
(P = 0.06) in RES groups. A decrease in CLOCK expression (P = 0.021) and PER2 expression
(P = 0.045) was observed among MEL groups. Additionally, a decrease in ARNTL expression
was observed in RES and MEL groups (P = 0.0003). Regarding main effects observed in
adipose-related genes (Figure 3.2) there was a decrease in AMPK expression in RES groups (P =
0.009) and a tendency for decreased AMPK expression in MEL groups (P = 0.077) versus CON
groups. a treatment x time interaction occurred in PPARG expression (P = 0.033), where
decreased expression was observed in the MEL-AM group versus the CON-AM group as well as
a tendency for decreased expression in the CON-PM group versus the CON-AM group was
observed (P = 0.064). For metabolomics in fetal loin muscle (figure 3.3) A diet x treatment
interaction was observed in growth-related transcription factor IGF1R (P = 0.047), where there
was a decrease in expression observed in the RES-MEL group (P = 0.032) compared to ADQMEL and RES-CON group. Myogenic expression analysis (figure 3.4) demonstrated a decrease
in MYF6 expression in MEL groups (P = 0.023). A diet effect showed a decrease in MYOD1
expression in RES groups (P = 0.001) and a tendency for decreased MYOG expression in RES
groups (P = 0.069). There were no differences observed in SCD, ADIPOQ, CRY1, CRY2, IGF1,
IGF2, IGF2R (P > 0.11) among treatments.
Results from samples obtained during the summer 2020 trial are shown in figures 3.53.8. ). Circadian gene expression (figure 3.5) showed a diet x time interaction (P = 0.002) in
ARNTL expression, where ADQ-PM, RES-AM and RES-PM had decreased ARNTL expression
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compared to ADQ-AM (P < 0.003). An diet x time interaction (P = 0.043) was observed for
CRY1 expression, the RES-AM had a tendency for decreased CRY1 expression compared to the
ADQ-AM group and RES-PM group (P = 0.10) and a tendency for decreased expression (P =
0.056) compared to the RES-PM group. There was a diet x time interaction tendency (P = 0.089)
observed where PER2 expression had a tendency to increase in the RES-PM group compared to
the ADQ-PM group (P = 0.052) and had increased expression in the RES-PM group versus the
ADQ-AM and RES-AM group (P < 0.014). There were no differences with CLOCK and CRY2
expression (P > 0.351). Figure 3.6 shows that there were no main effects on the expression of
adipose-related genes ADIPOQ, AMPK, CEBPA, SCD, and PPARG (P > 0.138).
Figure 3.7 shows expression of metabolomics gene expression. A diet x treatment x time
interaction was observed with IGF1 expression (P = 0.004), where expression in ADQ-MELAM group was increased (P < 0.002) compared to all other groups in the trial (ADQ-CON-AM,
ADQ-MEL-PM, RES-CON-AM, RES-CON-PM, RES-MEL-AM and RES-MEL-PM and ADQCON-PM group). Additionally, there was an increase in IGF1 expression in the RES-MEL-PM
group versus ADQ-MEL-PM group (P = 0.027). The RES-MEL-PM had a tendency for
decreased expression compared to ADQ-CON-AM (P = 0.096). A diet x time interaction was
observed in IGF2 expression (P = 0.026), where RES-PM had increased expression compared to
ADQ-PM and RES-AM (P < 0.034). There were no differences in expression of IGF1R and
IGF2R (P > 0.27).
Myogenic genes are displayed in Figure 3.8. A diet x time interaction (P = 0.006) was
observed in MYF6 expression, where the RES-PM group had increased expression compared to
ADQ-AM, ADQ-PM and RES-AM groups (P < 0.03). Additionally, MYF6 expression also had
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a treatment x time interaction (P = 0.010), where expression was higher in the CON-PM group
compared to the CON-AM group (P = 0.004); expression in the MEL-AM group was higher
than in CON-AM group (P = 0.026). Expression of MYF6 in the MEL-PM group tended to be
higher compared to the CON-AM group (P = 0.057). Additionally, expression of MYF6 in the
MEL-PM group tended to be lower than the CON-PM group (P = 0.067). A diet x treatment x
time interaction was observed in MYOG expression (P = 0.041). In terms of expression levels,
ADQ-CON-PM, ADQ-MEL-PM, RES-CON-PM and RES-MEL-PM had positive MYOG
expression in reference to pooled loin muscle control whereas ADQ-CON-AM, ADQ-MEL-AM,
RES-CON-AM, and RES-MEL-AM had negative MYOG expression in reference to pooled loin
muscle control. Overall, the RES-MEL-PM group experienced increased MYOG expression
compared to all other groups (P < 0.004). Followed by groups ADQ-CON-PM, RES-CON-PM
and ADQ-MEL-PM group showing increased MYOG expression compared to ADQ-CON-AM,
ADQ-MEL-AM, RES-CON-AM, and RES-MEL-AM (P < 0.002). Lastly, ADQ-MEL-AM had
increased MYOG expression compared to ADQ-CON-AM, RES-CON-AM and RES-MEL-AM
(P < 0.004). There were no differences observed in expression of MYOD1, MYF5 (P > 0.54).
3.5

Discussion
The present study demonstrated the effect of melatonin and feed restriction on circadian,

myogenic, adipogenic transcription in loin muscle. Gene expression in fetal loin muscle during
the fall 2019 trial (figure 3.1-3.4) experienced less differences towards altered expression.
However, it was noted that a decrease and a tendency for decreased AMPK was observed in the
RES and MEL groups. These reports support the mechanism involving AMPK activation
shifting adipocytes from an adipogenic and lipogenic state towards a state of lipolysis. An
increase in brown fat adipogenesis has been observed during colder seasons in order to reserve
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energy for metabolic purposes, namely thermogenesis (Seale et al., 2009). Furthermore,
melatonin has also been shown to mediate brown fat adipogenesis in seasonal animals (Lynch
and Epstein, 1975). It evident that photoperiod plays an important part in altered expression
patterns contributing to development and metabolism of muscle and adipose tissue. In nocturnal
animals such as mice, Hodge et al. (2015) determined circadian expression of fatty acid binding
protein transporter genes involved in lipid metabolism. Transcriptomic analysis suggested that
higher expression of fatty acid oxidation occurred in mice during their inactive period
(photophase) versus during their active period (scotophase), which favored lipogenesis for
energy reserve. Minami et al. (2009) also reported on differences in circadian oscillations of fatty
acid metabolites in blood samples taken from mice every 4 hours over different light: dark
exposure periods. At the time of fetal tissue collection in the fall trial, ambient temperature was
colder versus summer trial ambient temperature. This suggests that offspring programming
towards tissue prioritization towards colder weather is likely possible. Interestingly, an
interaction with time was observed where the CON-PM group and the MEL-AM group showed
decreased PPARG expression compared to the CON-AM and MEL-PM group. Melatonin has
the capacity to promote cell proliferation of tissues through activation of transcription factor
pathways (Xu et al., 2020). Therefore melatonin-mediated and photoperiod-influenced pathways
are critical towards altering adiposity. Circadian genes were downregulated in the RES group
and the MEL group. This may have been related to the downregulation of IGF1R in the RESMEL group compared to all other groups. Additionally, myogenic genes also experienced a
tendency in downregulation of MYOD1 and MYOG in the RES group and MYF6, MYF5 in the
MEL group. Figure 3.9 depicts the proposed pathway involving feed restriction, melatonin and
photoperiod on adiposity in skeletal muscle. It appears that as the photophase decreases when
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approaching winter, there is a shift in differentiation that favors adipogenesis over myogenesis.
The hypothesis is that the accretion of adipose tissue would be geared towards energy reserves
and thermogenesis for the winter months. This may have been reflected in the lack of differences
in loin muscle morphometrics as a compensatory approach within skeletal muscle.
From analysis of summer 2020 trial (figure 3.5-3.8), differential transcriptional
expression is observed when compared to the fall trial group. An upregulation of ARNTL was
observed in the ADQ-AM group versus other groups, verifying the influence of photoperiod and
feed availability. Interestingly, the highest expression levels were observed in the RES-PM and
ADQ-AM group. Reduced feed and scotophase period appear to serve as a driving force towards
inhibiting the potential activation of some genomic targets. In regard to metabolomics factors,
IGF1 expression was highest in ADQ-MEL-AM group versus all other treatments. The ADQCON-AM and ADQ-MEL-PM groups had the lowest IGF1 expression levels while all others
were intermediate. In IGF2 expression, the RES-PM and ADQ-AM had higher levels of
expression versus ADQ-PM. In terms of myogenic genes, a treatment x time and diet x time
interaction was observed, with CON-PM exhibiting increased MYF6 expression followed by
MEL groups as intermediates. In the longer day lengths, it appears that melatonin may have a
more influential effect on circadian patterns related to upregulating muscle development.
Expression of MYOG showed the highest expression in the RES-MEL-PM group, followed by
intermediate increased expression ADQ-CON-PM, ADQ-MEL-PM and RES CON-PM. An
inhibitory expression of MYOG was observed in ADQ-CON-AM, ADQ-CON-PM and RESMEL-AM. These differential expressions appear to indicate that melatonin, diet and photoperiod
are heavily influencing developmental and metabolomics gene expression that can’t fully be
explained by the circadian expressions analyzed in this study. Hodge et al. (2015) utilized RNA
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sequencing and determined over 1500 circadian mRNAs and Gene Ontology enrichment heavily
based on cellular metabolic processes, including carbohydrate and lipid utilization, as well as
storage and biosynthetic pathways. From our results, it appears that, in the summer trial, there is
greater expression of myogenic pathways. From a production standpoint, the RES-MEL group
and the ADQ-CON group had the highest loin muscle weights compared to the RES-CON and
ADQ-MEL group. On the contrary, the semitendinosus per fetal weight ratio increased in the
RES-CON and ADQ-MEL group. This conflicting data may imply that melatonin may have
influence in mitigating tissue degradation, while simultaneously having a selective influence in
tissue prioritization within skeletal muscle. The skeletal muscle is a highly metabolic organ
involving several processes. Figure 3. 10 depicts the proposed pathways involving feed
restriction, melatonin and photoperiod on skeletal muscle physiology. As the photophase
increases when approaching summer months, there is a shift in priority from adipose as a storage
reserve towards myogenesis, possible geared towards protein accretion and glucose homeostasis.
Increased myogenic pathways may be in favor of increasing metabolic efficiency as a
compensatory means. From our RNA sequencing analysis in chapter 2, we have established that
upregulation of genes involving protein synthesis can be related towards combatting decreased
angiogenic and circulatory factors during gestation. However, in this experiment, it is unclear of
the extent of combined interactions of nutrient restriction, melatonin secretions and photoperiod,
as well as independent circadian factors on the molecular, cellular and metabolomic implications
of these offspring onset adulthood and warrant further investigation.
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Table 3.1

Gene ID
ACTB
RPS9
IGF1
IGF1R
IGF2
IGF2R
ARNTL
PRKAA
CLOCK
CRY1
CRY2
PER2
MYF5
MYF6
MYOD1
MYOG
ADIPOQ
CEBPA
PPARG
SCD

Gene assays used for TaqMan real-time PCR quantification of fetal loin muscle
gene expression.
Gene Name
Beta-actin
Ribosomal Protein S9
Insulin-like Growth Factor 1
Insulin-like Growth Factor 1 receptor
Insulin-like Growth Factor 2
Insulin-like Growth Factor 2 receptor
Aryl Hydrocarbon Receptor Nuclear Translocator
Like 1 (BMAL1)
AMP-activated protein kinase (AMPK)
Clock Circadian Regulator
Cryptochrome Circadian Regulator 1
Cryptochrome Circadian Regulator 2
Period Circadian Regulator 2
Myogenic factor 5
Myogenic factor 6
Myogenic Differentiation 1
Myogenin (MYF4)
Adiponectin
CCAAT Enhancer Binding Protein Alpha
Peroxisome Proliferator Activated Receptor Gamma
Stearoyl-CoA Desaturase
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Assay ID
Bt03279174_g_1
Bt03272016_m1
Bt03252282_m1
Bt03649217_m1
Bt03259225_m1
Bt03223466_m1
Bt04302498_m1
Bt04283523_m1
Bt04656680_m1
Bt01553590_g1
Bt04735651_m1
Bt04311406_m1
Bt03223134_m1
Bt03224711_g1
Bt03244740_m1
Bt03258928_m1
Bt03292341_s1
Bt03224529_s1
Bt03217547_m1
Bt04307476_m1

Table 3.2

Fetal muscle morphometrics taken at day 240 of gestation in fall 2019 trial. Adapted from Contreras-Correa (2021)

Item

ADQ-CON

RES-CON

ADQ-MEL

RES-MEL

SE

Nut

Trt

Fetal Weight, kg

26.7a

23.3b

26.9a

24.6b

1.0

0.0087

0.2304 0.6166

Left LM, g

271.6

250.5

293.7

284.5

22.0

0.5736

0.3226 0.7920

Left LM/FW, g/kg

10.4

11.0

10.8

11.5

0.7

0.3492

0.3213 0.9551

Left LM length, cm

38.1

38.4

39.3

34.3

2.0

0.2354

0.4485 0.1851

Left LM width, cm

12.9

13.5

12.7

14.2

0.9

0.2152

0.7725 0.6484

Right LM, g

256.6

235.5

291.0

271.9

18.4

0.1681

0.0845 0.7664

Right LM/FW, g/kg

10.4

10.0

10.7

11.1

0.7

0.9557

0.1414 0.6070

STM, g/kg

92.7

82.9

92.1

97.0

7.4

0.7693

0.3427 0.3315

STM/FW, g/kg

3.6

3.6

3.4

3.9

0.2

0.1773

0.5836 0.2116
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Nut*Trt

Table 3.3

Fetal muscle morphometrics taken at day 240 of gestation in summer 2020 trial. Adapted from Contreras-Correa (2021)

Item
Fetal weight, kg
Left LM, g
Left LM/FW, g/kg
Left LM length,
cm
Left LM width, cm
Right LM, g
Right LM/FW,
g/kg
STM, g/kg
STM/FW, g/kg

ADQCON
24.40b
240.65ab

RESCON
21.00a
221.63a

ADQMEL
22.92ab
229.91a

RES-MEL
24.28b
261.70b

SE
0.93
10.76

Nut
0.199
0.497

Trt
Nut*Trt
0.89 0.029
0.192 0.034

9.77

10.1

10.13

10.68

0.46

0.293

0.283 0.765

36.09
11.09
237.05ab

36.0
9.9
206.96a

33.46
10.81
202.83a

36.5
10.52
251.71b

1.03
0.42
13.76

0.347
0.16
0.394

0.547 0.135
0.25 0.282
0.665 0.016

9.53
53.58
2.18a

9.74
58.9
2.66b

9.32
58.71
2.67b

10.22
61.83
2.36ab

0.41
5.34
0.13

0.152
0.392
0.499

0.683 0.414
0.64 0.834
0.456 0.007
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Figure 3.1

Relative quantification of fetal loin muscle gene expression (circadian) from samples taken at day 240 of gestation in
fall 2019 trial. Circadian-related genes include A) CLOCK1 (B) ARNTL (C) CRY1 (D) CRY2 (E) and PER2. An
asterisk (*) denotes significance at P ≤ 0.05 while a dagger (†) tendency was declared at 0.05 < P < 0.10.
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Figure 3.1

(Continued)
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Figure 3.2

Relative quantification of fetal loin muscle gene expression (adipose-related) from samples taken at day 240 of gestation
in fall 2019 trial. Adipose-related genes include (F) ADIPOQ (G) AMPK (H) PPARG and (I) SCD. An asterisk (*)
denotes significance at P ≤ 0.05 while a dagger (†) tendency was declared at 0.05 < P < 0.10. Interactions were
included when P < 0.10
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Figure 3.3

Relative quantification of fetal loin muscle gene expression (metabolomic) from samples taken at day 240 of gestation
in fall 2019 trial. Metabolomic genes include (J) IGF1 (K) IGF1R (L) IGF2 (M) IGF2R. An asterisk (*) denotes
significance at P ≤ 0.05 while a dagger (†) tendency was declared at 0.05 < P < 0.10. Interactions were included when
P < 0.10.
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Figure 3.4

Relative quantification of fetal loin muscle gene expression (myogenic) from samples taken at day 240 of gestation in
fall 2019 trial. Myogenic genes include (N) MYF5 (O) MYF6 (P) MYOD1 and (Q) MYOG. An asterisk (*) denotes
significance at P ≤ 0.05 while a dagger (†) tendency was declared at 0.05 < P < 0.10.
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Figure 3.5

Relative quantification of fetal loin muscle gene expression (circadian) from samples taken at day 240 of gestation in
summer 2020 trial. . Circadian genes include (A) CLOCK (B) ARNTL (C) CRY1 (D) CRY2 and (E) PER2. An asterisk
(*) denotes significance at P ≤ 0.05 while a dagger (†) tendency was declared at 0.05 < P < 0.10. Interactions were
included when P < 0.10.
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Figure 3.5

(Continued)
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Figure 3.6

Relative quantification of fetal loin muscle gene expression (adipose-related) from samples taken at day 240 of gestation
in summer 2020 trial. Adipose-related genes include (A) ADIPOQ (B) AMPK (C) CEBPA (D) PPARG and (E) SCD.
An asterisk (*) denotes significance at P ≤ 0.05 while a dagger (†) tendency was declared at 0.05 < P < 0.10.
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Figure 3.6

(Continued)
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Figure 3.7

Relative quantification of fetal loin muscle gene expression (metabolomic) from samples taken at day 240 of gestation
in summer 2020 trial. Metabolomic genes include (K) IGF1 (L) IGF1R (M) IGF2 (N) IGF2R. An asterisk (*) denotes
significance at P ≤ 0.05 while a dagger (†) tendency was declared at 0.05 < P < 0.10. Interactions were included when P
< 0.10.
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Figure 3.8

Relative quantification of fetal loin muscle gene expression (Myogenic) from samples taken at day 240 of gestation in
summer 2020 trial. Myogenic genes include (O) MYF5 (P) MYOD1 diet x time interaction (Q) MYF6 treatment x time
interaction (R) MYF6 diet x time interaction and (S) MYOG. An asterisk (*) denotes significance at P ≤ 0.05 while a
dagger (†) tendency was declared at 0.05 < P < 0.10. Interactions were included when P < 0.10
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Figure 3.8

(Continued)
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Figure 3.9

Proposed Pathway of external effects on skeletal muscle and adiposity in beef
cattle during fall 2019 trial. As the winter approaches circadian factors are
influenced through direct and indirect pathways mediated by increased melatonin
levels and feed restriction. These influences are believed to downregulate factors
involving adipogenesis of White Adipose tissue (WAT), including AMPK, while
upregulating factors involving lipogenesis of Brown Adipose Tissue (BAT). This
would create a shift from muscle development towards adipose accretion geared
towards lipid reserves for energy and thermogenesis during the colder months.
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Figure 3.10

Proposed Pathway of external effects on skeletal muscle in beef cattle during fall
2020 trial. During longer photoperiods in the summer months, melatonin and feed
restriction alter myogenic pathways that prioritize muscle development and
glucose homeostasis instead of adipose-related mechanisms. These influences of
melatonin and feed restriction on myogenesis are contingent upon the time of day
as differences in expression between the photophase and scotophase periods are
apparent.
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CHAPTER IV
EFFECT OF PRENATAL AND POSTNATAL MELATONIN SUPPLEMENTATION ON
OFFSPRING MORPHOMETRICS, PERFORMANCE TRAITS, AND TESTICULAR
PHYSIOLOGY IN BEEF CATTLE
4.1

Abstract
Melatonin has been documented to alleviate compromised pregnancies and enhance

livestock performance traits. The objective of this study was to determine the effect of prenatal
and postnatal melatonin supplementation on overall calf performance, including birth and
weaning measurements, molecular growth factors as well testicular physiology in subsequent
bull calves. Additionally, dam milk characteristics were analyzed to determine alterations in milk
weight and quality in relation to calf performance. Cows (n= 60) were blocked based on embryo
transfer donor and sire, potential calf breed and embryo grade. At day 190, 220 and 250 of
gestation, dams were administered either 2 subdermal ear melatonin implants (preMEL) or no
implants (preCON). After parturition, birth weights were recorded and calves were blocked
based on prenatal treatment and sex. Calves received either melatonin implants (posMEL) or
none (posCON) on approximately day 0, 30, and 60. At approximately day 60 of lactation, a
subset of dams (n= 32) were selected based on age, weight and calf sex for milk collection and
analysis. At weaning, (day 210 postnatally) calf weight and morphometric data were collected.
Liver and loin muscle samples were collected for gene expression analysis. When bulls (n = 30)
were 12 months of age, scrotal circumference measurements were taken. Additionally, Doppler
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ultrasonography and thermal imaging was used to record and analyze mean testicular blood flow
and temperature. When bulls were approximately 14 months old, carcass measurements were
taken using ultrasonography. Milk yield and fat percent from dams tended to decrease in the
preMEL group (P < 0.07). Prenatal melatonin administration decreased head circumference in
calves at weaning age (P = 0.03). A tendency for decreased MYF5 and MYOD1 expression in
loin muscle was observed in the posMEL calves. Otherwise, there were no differences in calf
performance measurements (P > 0.12). Prenatal and postnatal melatonin administration did not
affect bull testicular hemodynamics, scrotal measurements, and testicular temperature (P >
0.14). Carcass ultrasonography results showed no prenatal or postnatal treatment effect on ribeye
area, back fat thickness and percent intramuscular fat (P > 0.16). These results demonstrated that
administering supplemental melatonin via implants during the prenatal and postnatal phase did
not alter performance characteristics in offspring. Blood analysis demonstrated that plasma
melatonin levels were not different (P = 0.12) in dams implanted with melatonin versus control
dams. Whereas, an increase in plasma melatonin levels in posMEL versus posCON calves (P =
0.0003) was observed. In this study, dams were implanted in winter months, whereas calves were
implanted in the spring months. Seasonal differences involving photoperiod and ambient
temperature might be attributed to a lack of differences in melatonin levels during the prenatal
phase. In the postnatal period, the level of developmental plasticity appears to be too low for
melatonin properties to be effective. Additionally, other external factors, such as nutrient plane
may influence observations of melatonin-mediated alterations. A further investigation of sperm
parametrics is warranted to determine the full extent of melatonin supplementation on early
development in relation to fertility.
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4.2

Introduction
It has been established that the fate of prenatal and postnatal growth is dependent upon

the regulation of transcription factors and hormone signaling pathways that lead to proliferation
and differentiation of tissues. A majority of studies place an emphasis on the negative
implications of programming due to adverse maternal plane, namely maternal undernutrition
otherwise known as maternal nutrient restriction. This is due to the lack of nutrient availability
for the dam to properly develop an optimal placenta for nutrient uptake, and the lack of nutrients
that the fetus ultimately gains for growth. During postnatal life, programming can be dependent
on milk or feed quality which can affect hypertrophy in tissues such as muscle and adipose or in
proliferation and differentiation in certain cells such as the Sertoli and Leydig cells in testes.
Negative impacts of prenatal and postnatal programming have been observed in relation to
immune cell proliferation (Hu et al. 2015; Baek et al., 2019). Additional therapeutic research is
in high demand for mitigating some of these developmental and physiological issues.
The tryptophan-derived hormone, melatonin, has emerged as a promising therapeutic in
benefiting programming during early life due to its mediated pathways involved in vasodilation,
hormone signaling pathways and antioxidant capacity. Melatonin/melatonergic receptors are
located in several cells, including adipocytes (Brydon et al., 2001), and sertoli and Leydig cells
(Frungieri et al., 2005; Yang et al., 2014; Gonzalez-Arto et al., 2017). Melatonin administration
has shown to decrease hCG-stimulated cAMP by means of stimulating local testicular
Corticotropin-Releasing Hormone. This caused subsequent decreased steroidogenic enzyme
activity and decreased androgens in the Syrian hamster (Frungieri et al., 2005; 2017).
Simultaneously, in the Syrian hamster it was also shown to upregulate Brown Adipose Tissue
synthesis (Viswanathan et al., 1986). Contrary to this, in white adipocytes, melatonin appears to
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have a lipolytic effect (Puchalski et al., 1988; Rasmussen et al., 1999; Wolden-Hanson et al.,
2000). It is believed that day length and seasonal effects allow for melatonin secretion to
influence tissue prioritization. Recent studies have demonstrated melatonin’s ability to increase
antioxidant capacity, milking traits in dams, fetal and calf performance and testicular
morphometrics (Lemley et al., 2012; Brockus et al., 2016a; 2016b; McCarty et al., 2018).
Evidence of prenatal melatonin administration has been promising; however, evidence of
observing these benefits during postnatal administration are virtually non-existent. Therefore, the
purpose of this study was to analyze the effects of prenatal and postnatal melatonin
supplementation on dam milking traits, morphological and molecular calf performance
measurements, testicular physiological traits, and carcass traits of offspring.
4.3
4.3.1

Materials and Methods
Animal Care and Treatment
This experiment was performed at the United States Department of Agriculture-

Agricultural Research Service (USDA-ARS) Fort Keogh Livestock and Range Research
Laboratory in Fort Keogh, Miles City, Montana. Animal care and use was approved by the
Institutional Animal Care and Use Committee (IACUC # 082919-1 and # 120418-2). Embryos
originating from 2 sires and 15 donors transferred to recipient cows (n= 75) on June 29, 2018
and June 30, 2018. Sixty-seven of the recipients that were confirmed pregnant were enrolled in
the study prior to treatment administration. From the group, sixty of the dams calved
successfully. The calf breed was a combination of 28 Angus and 32 Angus x Polled Hereford
calves.
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At the start of gestation, dams were strictly grazed on pasture consisting of native grass
until January 9, 2019, when cows were supplemented with approximately 5.44 kg of alfalfa hay
(20% CP) daily. Approximately 30 days before parturition, cows were moved to another pasture
and provided a full alfalfa hay diet.
Prior to administering melatonin treatment, cows were blocked based on embryo transfer
donor, sire, potential calf breed, dam (recipient) age and embryo grade. On day 190 of gestation,
dams were assigned to one of the allotted treatments: melatonin implanted (preMEL) or no
melatonin implanted (preCON); this provided fetuses with a prenatal melatonin
supplementation. At the time of implantation, sixty dams maintained their pregnancy to continue
the study. Melatonin implants were administered using 2 sub-dermal ear implants (Melatonin
Implants, Conroe, Texas, USA). Each implant contained 24mg of melatonin which slowly
released into the peripheral circulatory system over a 30-day period. Dams were implanted again
on day 220 and lastly on day 250 of gestation (every 30 days). After parturition, calves were
assigned into either one of two postnatal treatments: Melatonin administered, again using the
same 2 sub-dermal ear implants at 24mg per implant (posMEL) or no melatonin implantation
(posCON) on day 0, 30 and 60 after parturition. Figure 4.1 shows a schematic diagram of the
treatment design and allotted groups, creating an overall 2 x 2 factorial design.

4.3.2

Blood Collection
In dams, blood samples were collected at day 250 of gestation. Blood was collected using

18 gauge, 1 inch needles and 10 mL vacutainer tubes containing 0.10 ml of 15 % K3EDTA for
plasma analysis. Blood was collected in calves at day 60 after parturition using 20 gauge, 1 inch
needles and 10 mL vacutainer tubes containing 0.10 ml of 15 % K3EDTA vacutainer. Blood
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samples were analyzed for plasma melatonin concentrations in peripheral circulation using a
commercial melatonin ELISA kit (TECAN, Morrisville, NC, USA) as described in McCarty et
al. (2018). A melatonin standard curve (0-1000 pg/mL) was used as a reference for samples;
sensitivity of the test was 1.0 pg/mL. The intra-assay coefficient of variation for the melatonin
assay was 12.2% in dams and 18.1% in calves.
4.3.3

Milk Data Collection from Dams
At approximately day 60 of lactation, a subset of dams (n=32) were selected based on

age, weight and calf sex for milk evaluation. Data from dams were collected over a 2-day period
between 07:00 to 20:30 hr. Each dam was caught in a hydraulic chute and administered an
intramuscular injection of 2 mL of oxytocin (40 USP; Valley Vet Supply, Marysville, KS, USA),
followed by a 5-minute wait period. A milking machine was used to collect milk. After which,
the dam was released from the chute and after approximately 6 hours, the dam was recaptured
and given a second administration of oxytocin for a second milk collection. Each dam was
milked for an average of 15 minutes, except when the dam appeared to need more or less time
for complete milking. The weights from the second milk collection were recorded and aliquoted
into 50 mL milk chemical analysis tubes (National Dairy Herd Improvement Association) and
immersed in ice (~2 °C) and shipped the following day for analysis (Rocky Mountain DHIA,
North Logan, UT, USA).
4.3.4

Morphometric Data Collection
During the weaning period (approximately day 210 after parturition) morphometric

measurements were taken from all calves over a 2-day period. The measurements included
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weight, curved crown-to-rump length (CCR), hip height, head length and head circumference.
Measurements were taken with a measuring tape by one individual for precision.
4.3.5

Biopsy collection
Along with morphometric data collection, biopsies were collected from weaned calves

over a 2-day period (IACUC # 082919-1). All animals received an intravenous injection of 50
mg/mL Banamine ® (Merck Animal Health, Madison, NJ, USA). Dose was calculated based on
individual body weight using manufacturer’s instructions (1.1-2.2 mg per kg in cattle).
Loin muscle biopsies were collected firstly by using clippers (#10 followed by and #40
blade) to shave approximately an area of 6 x 6 cm. The shaved area was distal to the last rib and
lateral to the spine. Gauze pads soaked in 0.75% povidone-iodine, followed by gauze pads
soaked with 2% chlorohexidine solution, followed by gauze pads soaked in 70% ethanol were
used to clean and disinfect the area before puncture. Before puncture, 0.5 - 1 cc of 2% lidocaine
(Valley Vet Supply, Marysville, KS, USA) was administered subcutaneously. An 8-gauge, 3.2
mm x 48 mm puncture needle (Painful Pleasures, Hanover, MD, USA) that was sterilized with
the chlorohexidine solution and rinsed with sterile saline was used to puncture the hyde. A
sterilized and saline-rinsed 10-gauge x 5cm biopsy needle (Cook Incorporated, Bloomington, IN,
USA) was used to obtain a sample notch of at least 100 mg (20mm) of tissue per biopsy (4
biopsies total). Samples were immediately snap-frozen in liquid nitrogen and stored at -80
degrees Celsius. The area was cleaned with gauze soaked with ethanol followed by
chlorohexidine, followed by betadine (Povidone-Iodine, 5%), then disinfected with Blue-Kote®
germicidal spray, then Alushield® aerosol bandage spray to seal puncture.
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Concurrently, liver biopsies were collected using the same clippers to shave a 3 x 3 inch
area overlapping the 10th and 11th rib, approximately 15-18 cm lateral to the spine. A total of 4 cc
of 2 % lidocaine was injected subcutaneously. After a 2-minute wait period, the same puncture
needle was used to target the intercostal space between the 10th and 11th rib. After which, a 12gauge x 10 cm biopsy needle (Bard Peripheral Vascular Inc., Tempe, AZ, USA) was inserted in
between the intercostal space. Midway through the insertion of the biopsy needle, the angle was
titled to a 60-degree angle to target the liver. Two sample notches measuring approximately
17mm were obtained. Samples were immediately snap-frozen in liquid nitrogen and stored at -80
degrees Celsius. The cleaning, disinfecting and bandaging procedures before and after the biopsy
were synonymous to that of the loin muscle procedure.
4.3.6

Testicular Doppler Ultrasonography
When bull calves were 12 months of age, hemodynamic measurements of the testes were

recorded (IACUC # 120418-2). A color Doppler ultrasonography machine (MicroMaxx;
SonoSite, Inc., Bothell, WA, USA) was used between 07:00 and 13:00 hr. All bulls were
analyzed over a 3-day period. Measurements were taken on the left and right testis using the
ultrasound probe to locate the pampiniform plexus within the spermatic cord. On average, three
cardiac cycle waveforms were taken from each testis. These were used to calculate systolic
velocity (S; cm/s), diastolic velocity (D; cm/s), as well as the systolic: diastolic ratio (S/D).
Pulsatility index (PI) and resistance index (RI) were also obtained. Mean velocity (MnV) was
calculated using the formula: (S-D)/PI. Testicular artery blood flow was calculated using the
formula: (MnV*vessel area*60 s) on the right and left testes; then values from both testes were
combined to generate total testicular artery blood flow.

111

4.3.7

Testicular Thermal Imaging Scrotal Circumference
Yearling bulls were subject to thermal imaging using a Flir T540 infrared Thermal

Imaging Camera (Flir Systems, Boston, MA, USA) on testes (IACUC # 120418-2). Prior to
thermal imaging, ambient temperature was recorded under minimal draft conditions. Due to
weather conditions, all testes were gently pulled downward and quickly shaved (approximately
5-7 seconds) with #10 blade clippers. In order to minimize potential heat transference for thermal
images, there was a 20-second wait period after contact with testes before the images were taken.
The average temperature of testes was determined by utilizing ThermaCAM Researcher Pro 2.7
software (FLIR Systems, Boston, MA, USA). To determine this, a polygon that corresponded to
the entire area of testes was operated alongside temperature gradient change of the polygon.
Scrotal circumference was measured with scrotal tape and recorded.
4.3.8

Carcass Ultrasonography
Measurements were taken at 14 months of age using a carcass ultrasonography probe.

The probe was placed between the 12th and 13th ribs in order to determine the ribeye area (REA),
rib fat/back fat (BF), and percent intramuscular fat (IMF).
4.3.9

RNA Extraction and Gene Expression
Liver and loin muscle biopsy samples were processed for RNA extraction.

Approximately 200 mg (loin muscle) or 100 mg (liver) of tissue was suspended in Qiazol ™
Lysis buffer and isolated using the protocol from the miRNeasy mini kit (QIAGEN,
Germantown, MD, USA). Concentrations of RNA were measured using a Nanodrop ™ One
Microvolume UV-Vis Spectrophotometer (Thermo Fisher Scientific, Auburn, AL, USA). Loin
muscle samples were diluted to a standard of 40 ng/µl and liver samples were diluted to a
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standard of 100 ng/µl. A total of 10 µl of RNA was combined with 10 µl of PCR reaction
cocktail prepared from a High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher
Scientific, Auburn, AL, USA) for generation of cDNA. Aliquots of cDNA were made at a ratio
of 1:20. Expression of adipogenic and myogenic genes was analyzed utilizing TaqMan ® Assays
depicted in Table 4.1 (Thermo Fisher Scientific, Auburn, AL, USA). Quantification in a 96-well
plate was used at a final volume of 10 µl (each well contained 1 µl cDNA and 9 µl of TaqMan ®
reagent cocktail) with 4 replicates for each sample-gene analysis. Plates were read using a
QuantStudio™ 3 Real-Time PCR system (Applied Biosystems, Foster City, CA, USA). Raw
data was analyzed using the 2-ΔΔCt method. The geometric mean of Beta Actin and RPS9 was
used as a reference to normalize all the selected gene expression data.
4.3.10

Statistical Analysis
Data were analyzed using the mixed procedure of SAS version 9.4 (SAS Institute, Cary,

NC, USA). Dam data were analyzed as a Randomized Block Design using ANOVA. The model
included the fixed effects of prenatal (maternal) treatment. The blocks included were embryo
transfer donor, sire, potential calf breed, dam (recipient) age, embryo grade and. Calf data were
analyzed as a 2 x 2 factorial design using ANOVA. The main effects were prenatal treatment and
postnatal treatment. Calves were blocked based on dam blocks, in addition to calf sex.
Covariates were weaning age and gestation length. In calves, the main effects were reported as
prenatal treatment, postnatal treatment and their interactions. All interactions, blocks and
covariates within the model were removed when P ≥ 0.10. Least square means and standard error
of the means are reported. Statistical significance was declared at P ≤ 0.05 while a tendency was
declared at 0.05 < P ≤ 0.10. The univariate procedure was used for determination of normalized
distribution in total testicular blood flow and the correlation procedure was used for testicular
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parametric associations. Statistical significance was declared at P ≤ 0.05 while a tendency was
declared at 0.05 < P ≤ 0.10.
4.4
4.4.1

Results
Blood Analysis, Dam Milk, Calf Morphometrics, Biopsy Gene Expression and
Calf Carcass Traits
Table 4.2 shows the differences in plasma levels within dams treated with melatonin

versus control dams and calves subjected to prenatal and postnatal treatments. There were no
differences in plasma melatonin levels observed between MEL and CON dams taken at day 250
of gestation (P = 0.12). In calves, there were no differences between preMEL and preCON
groups taken at day 60 after birth (P = 0.96). Meanwhile a postnatal treatment effect was
observed (P = 0.0003) where posMEL calves had increased plasma melatonin levels at 32.19 ±
0.90 compared to posMEL calves at 9.17 ± 3.45 pg/mL.
Dam milk analysis displayed a tendency for a decrease in total milk yield (P = 0.054) in
MEL dams compared to CON dams (Table 4.3). Additionally, a day effect (P < 0.0001) was
observed for milk yield. A tendency for a decrease in total solids (P = 0.08) and fat percent (P =
0.07) was observed in MEL versus CON dams (Table 4.3); a sex effect (P = 0.04) was also
observed for milk fat. Protein, lactose, solid non-fat, somatic cell count and milk urea nitrogen
were not different (P > 0.16) between treatments.
Birth weight was not different (P = 0.96) in calves born from MEL dams versus calves
born from CON dams (preMEL versus CON calves). After calves were allotted to their
respective postnatal treatments, at day 210 morphometric results (Table 4.4) showed a decrease
in head circumference (P = 0.025) in PreMEL calves compared to PreCON calves. A sex x
treatment interaction (P = 0.007) was observed with hip height (Figure A.1) where PreMEL
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heifers had an increase in hip height (117.57 ± 1.21) compared to PreMEL bulls (110.73 ± 1.20)
and PreCON heifers and bulls (113.10 ± 1.51; 113.48 ± 1.20). A sex effect was observed for
head length (P = 0.002) and a sire effect was observed for CRL (P = 0.002). Otherwise, there
were no differences in morphometric measurements (P > 0.11) or weaning weights (P = 0.95) at
day 210 among prenatal and postnatal treatments. Figure 4.2 displays liver gene expression in the
prenatal and postnatal treatments. There were no differences observed (P > 0.314) for AMPK,
IGF1, IGF1R, PPARG expression in melatonin versus control groups. Loin muscle gene
expression results (Figure 4.3) show that in the prenatal treatment groups, there was a tendency
for AMPK downregulation (P = 0.060) observed in the PreMEL group versus PreCON. In the
postnatal treatment groups, a tendency for downregulation of MYF5 (P = 0.056) and MYOD1 (P
= 0.054) was observed in PosMEL group versus PosCON group. Otherwise no differences were
found in LM gene expressions among treatments. A sex effect (P < 0.01) was observed in
AMPK, IGF1, IGF1R, MYF5, MYF6, MYOD1 expression. The negligible differences in
metabolomic gene expression in weaning was reflected in carcass characteristics at
approximately 14 months of age. Overall, there were no differences observed (P > 0.17) among
treatments regarding rib eye area, rib (back) fat and intramuscular fat. A sire effect was observed
(P = 0.01) in regard to ribeye area.
4.4.2

Testicular Doppler Ultrasonography Testicular Thermal Imaging and Scrotal
Circumference
Figure 4.4 shows the main effects on testicular hemodynamics. At yearling age (12

months), there were no differences found among treatments (P > 0.32) regarding total blood
flow, PI, RI and average artery area. A sire effect (P = 0.01) was observed for total testicular
blood flow and a sire effect tendency was observed for average vessel area (P = 0.053). The
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average rate of total blood flow per bull (n= 30) was 138.04 ± 36.41 ml/min. The 5% interval
was 82.26 ml/min, the median was 133.30 ml/min and the 95% interval was 202.98 ml/min.
There was a negative correlation associated between PI and RI at r = 0.97 (P < 0.0001).
However, there was no association between PI or RI in relation to blood flow (P > 0.60).
Additionally there was no association between testicular temperature and blood flow, average
diameter, PI or RI (P > 0.50). Scrotal circumference analysis demonstrated that there were no
differences among prenatal and postnatal treatments (P > 0.15). The correlation analysis showed
no association between total blood flow and scrotal circumference (P > 0.15).
4.5

Discussion
Previous studies revealed that melatonin improved offspring performance. In dairy cattle,

there were no differences observed in birth weights between calves born to melatonin treated or
control treated dams. However, as time progressed towards the weaning period, differences in
body weights were observed with calves from MEL dams experiencing an increase in weight
during week 8 and 9 after birth (Brockus et al., 2016). Similarly in beef cattle, McCarty et al.
(2018) also found no differences in birth weights. However, at birth the ponderal index
(BW /Curved-Crown-Rump) in offspring born from MEL dams was greater. Furthermore, at
weaning age (day 195), the MEL calves had greater weights. The mechanisms involved are
unclear, however it may be more efficient homeostasis pathways within skeletal muscle. It might
be that efficient glucose uptake may play a role in increasing hypertrophy in tissues. Dam
morphometric analysis demonstrated a tendency toward decreased milk yield and fat percentage
in MEL dams versus CON dams. On the contrary, in dairy animals Brockus et al. (unpublished)
observed an increase in milk weights of MEL dams versus CON dams. Although dams were not
on implants during time of collection, tendencies may suggest a residual effect of melatonin
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shifting adipose reserves in mammary tissue. Moreover, weaned calves born experienced no
differences among treatments. This poses a question on whether melatonin has a delayed
response in altering feed efficiency since calves born from MEL dams tended to receive less
milk and milk fat.
A further observation of carcass trait analysis demonstrates no differences in REA, rib
back fat and IMF. Although no differences were observed since initial collections at birth, in the
McCarty (2018) determined that there were no differences in characteristics in offspring born
from MEL dams. In the case of altering diet for observing programming effects, Long et al.
(2021) demonstrated that dietary restriction altered fat depots in calves at an early postnatal
stage; however as these animals had their feed realimented towards an adequate and high energy
diet, these offspring had no differences in carcass traits at time of slaughter as well as no
differences in meat tenderness and subsequent cooking characteristics. Milk characteristics in
this study showed a tendency toward milk weight and fat reduction. Melatonin has been known
to have lipolytic properties towards white adipose tissue and adipose derived stem cells (Brydon
et al., 2001; Heo et al., 2019). However these tendencies appear negligible towards calf nutrition
and subsequent performance. One prominent observation in this study was that there were no
differences in maternal plasma melatonin levels in the prenatal phase. Dams were implanted
from December to February. This along with the geographical location of the experiment site,
fostered a higher scotophase photoperiod. This would increase melatonin secretion, therefore
making the supplementation negligible.
To our knowledge, this study is the first of its kind to jointly assess the effects of prenatal
and postnatal melatonin supplementation. Plasma serum levels in posMEL calves increased;
calves were implanted from March to June, a period that fostered a higher photophase period.
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Nevertheless, results in the postnatal group showed a lack of differences. This suggests that the
developmental plasticity hypothesis conceptualized by Bartol et al. (2013) may not apply in the
case of using melatonin as a performance enhancer. It is possible that melatonin’s vasodilatory
action towards the placenta may be the most influential property for enhancing performance.
Surprisingly, there was a tendency for a decrease in expression of myogenic genes MYF5 and
MYOD1 in posMEL calves versus posCON. These factors are prevalent during the prenatal
phase and decrease in expression as muscle hyperplasia becomes complete at birth. However,
satellite stem cells are capable of temporal reactivation early prenatal transcription factors, such
as Pax7, MYF5 and MYOD1 for muscle regeneration under the influence of certain stimuli
(Yablonka-Reuveni and Rivera, 1994). This may suggest that posMEL calves may have the
potential of less satellite cell activation compared to the posCON group. Interestingly, a
melatonin-mediated pathway involving satellite cells and muscle injury (a common promoter of
satellite cell activation) may be at play and warrants further investigation.
In regard to bull testicular characteristics, there were no differences observed in testicular
total blood flow, scrotal circumference and average testicular temperature. Furthermore a
correlation analysis showed that there was no correlation of testicular blood flow with average
testicular temperature. The morphometric results in this study differ compared to the results of
McCarty et al. (2018) who reported an increased scrotal circumference and testicular weights in
bull calves born from MEL dams at the time of weaning. It appears that for testicular growth and
differentiation, the prenatal period is the critical window for melatonin’s effect on developmental
plasticity. Sertoli cells rely on glucose transporters for glucose and subsequent lactate
production. Melatonin is shown to alter lactate production, with a decrease in basal lactate and an
increase in insulin dependent lactate production (Rocha et al., 2014). The potential increase in
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nutrient uptake from placenta transfer may have resulted in more efficient testicular uptake for
Sertoli cell proliferation and differentiation. Additionally, oxidative stress mechanisms may play
a part in reduction of apoptosis during fetal development.
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Table 4.1

Gene assays used for TaqMan real-time PCR quantification of loin muscle gene
expression

Gene ID
ACTB
RPS9
IGF1
IGF1R
IGF2
IGF2R
PRKAA2
MYF5
MYF6
MYOD1
ADIPOQ
PPARG

Table 4.2

Gene Name
Beta-actin
Ribosomal Protein S9
Insulin-like Growth Factor 1
Insulin-like Growth Factor 1 receptor
Insulin-like Growth Factor 2
Insulin-like Growth Factor 2 receptor
AMP-activated protein kinase (AMPK)
Myogenic factor 5
Myogenic factor 6
Myogenic Differentiation 1
Adiponectin
Peroxisome Proliferator Activated Receptor Gamma

Assay ID
Bt03279174_g_1
Bt03272016_m1
Bt03252282_m1
Bt03649217_m1
Bt03259225_m1
Bt03223466_m1
Bt04283523_m1
Bt03223134_m1
Bt03224711_g1
Bt03244740_m1
Bt03292341_s1
Bt03217547_m1

Plasma melatonin levels of dams taken at day 250 of gestation and calves taken at
day 60 after parturition. Superscripts signifies a significant difference at P =
0.0003.

Plasma Melatonin

Prenatal (Maternal) Treatment
CON
MEL P-value
17.14 ±
2.20

0.122

Dams

12.11 ±
2.20

20.54 ±
3.60

0.957

Calves

20.82 ±
3.45
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Postnatal Treatment
CON
MEL
P-value

9.17a ± 32.19b ±
3.45
0.90

0.0003

Table 4.3

Milk measurements taken from a subset of dams (n=32) at day 60 of lactation

Dependent Variable
Total Milk, g

Prenatal (Maternal) Treatment
P-value
MEL

CON

2367.69 ± 110.22

2054.48 ± 110.44

0.054

Fat, %

3.48 ± 0.21

3.01 ± 0.24

0.071

Protein, %

3.35 ± 0.08

3.49 ± 0.08

0.226

4.95 ± 0.11

4.99 ± 0.11

0.780

9.26 ± 0.10

9.46 ± 0.10

0.163

12.85 ± 0.25

12.85 ± 0.20

0.081

Somatic Cell Count

146.69 ± 39.10

119.13 ± 39.10

0.622

Milk Urea Nitrogen (MUN)

15.55 ± 0.51

14.81 ± 0.51

0.316

Lactose, %
Solid Non-Fat, %
Total Solids, %
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Table 4.4

Birth weight and Weaning morphometric measurements (analyzed at day 210) of
calves subjected to prenatal and postnatal treatments

Dependent Variable
Birth Weight, kg

39.94 ±
0.74

39.89 ±
0.68

CON

Postnatal Treatment
MEL
P-value

0.955
0.119

255.59 ±
3.72

255.90 ±
3.33

0.951

Weaning Weight, kg

259.74 ± 251.76
3.66
± 3.39

CCR1, cm

152.47 ± 152.23
1.22
± 1.13

0.883

153.72 ±
1.25

150.98 ±
1.11

0.107

113.79 ± 114.05
1.02
± 0.91

0.850

114 ±
1.03

113.83
±0.90

0.902

Hip Height, cm

Head Circumference, 79.32 ±
cm
0.45

77.87 ±
0.42

0.025

78.10 ±
0.46

79.09 ±
0.41

0.118

37.19 ±
0.21

36.99 ±
0.19

0.498

36.99 ±
0.21

37.20 ±
0.19

0.451

Head Length
1

Prenatal Treatment
CON
MEL P-value

Curved-crown-rump length
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Table 4.5

Scrotal circumference and average testicular temperature analyzed in offspring
yearling bulls (12 months of age) subjected to prenatal and postnatal treatments

Dependent Variable
SC1, cm
Average Testicular
Temperature, °C
1

CON

31.45 ±
0.48

31.66 ±
0.52

0.766

31.47 ±
0.53

31.64 ±
0.47

0.817

31.61 ±
1.89

32.77 ±
1.27

0.519

33.51 ±
1.30

30.87 ±
1.13

0.140

Scrotal Circumference

Table 4.6

Carcass characteristics analyzed at 14 months of age in offspring bulls subjected to
prenatal and postnatal treatments
Postnatal Treatment
MEL
P-value

Prenatal Treatment
CON
MEL P-value

CON

Rib Eye Area, cm2

30.87 ±
0.57

30.81 ±
0.61

0.939

30.24 ±
0.63

31.44 ±
0.55

0.166

Rib (Back) fat, cm2

0.39 ±
0.02

0.38 ±
0.02

0.601

0.37 ±
0.2

0.40 ±
0.02

0.208

3.53 ±
0.22

3.19 ±
0.23

0.305

3.52 ±
0.24

3.20 ±
0.21

0.346

Dependent Variable

1

IMF , %
1

Postnatal Treatment
MEL
P-value

Prenatal Treatment
CON
MEL P-value

Intramuscular Fat
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Figure 4.1

Schematic diagram of treatment design in a 2 x 2 factorial design. Prenatal and
postnatal treatment created 4 treatment groups in calves: preCON-posMEL,
preCON- posCON, preMEL-posMEL, preMEL-posMEL.
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Figure 4.2

Liver biopsy analysis taken from calves at weaning age (day 210) showing the relative quantification of metabolomic
factors (A) AMPK, (B) IGF1, (C) IGF1R (D) PPARG
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Figure 4.3

Loin muscle biopsy analysis taken from calves at weaning age (day 210) showing the relative quantification of
metabolomics, adipogenic and myogenic factors. A dagger (†) signifies a tendency at 0.05 < P ≤ 0.10.
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Figure 4.3

(Continued)
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Figure 4.3

(Continued)
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Figure 4.4

Testicular hemodynamics taken at 12 month of age in yearling bulls showing (A) total arterial blood flow (B) Blood
Vessel Area (C) Pulsatility Index and (D) Resistance Index
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CHAPTER V

CHAPTER V
GENERAL DISCUSSION
Developmental programming is a life-altering process that can change the outcome
of one’s life. For the duration of pregnancy, external factors can affect placental physiology and
cause subsequent changes. The placenta relies on characteristics, including vessel area,
circumference and perimeter for the optimal flow of blood and transfer of nutrients and
transporters to the fetus. Most of the literature shows evidence of negative programming and the
consequences that are as a result. From epidemiological studies conducted by several groups
(Barker and Osmond, 1988; Barker et al. 1990; de Rooji et al. 2006) the phenomenon of tissue
development alteration, biochemical imbalances have connected the early stages of life
with metabolic disorders emerging in the period of adulthood. The most prominent research
towards programming is geared towards maternal nutrient imbalance, including
undernourishment and overnourishment of general caloric intake (Lekatz et al., 2013). Other
studies focus on specific nutrient imbalances, including protein restriction (Petrik et al., 1999).
This can be further classified into a subgroup, where specific amino acids are analyzed to
determine their impact in total diet formulation (Mortensen et al., 2010). These factors along
with other researched external factors, including heat stress and fetal overcrowding, lead to
placental insufficiency (Dwyer et al. 2005; Arroyo et al., 2010). In the case of this study, nutrient
restriction, on the molecular level, led to downregulation of angiogenic and circulatory
transcription factors involved in blood vessel and connective tissue development. On a cellular
level, blood vessel characteristics were not altered in regard to blood flow but were upregulated
in regard to characteristics relating to nutrient transport. Furthermore, molecular factors
involving protein synthesis were upregulated. This suggests that in the event of dietary
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restriction, the placenta will utilize ribosomal and translation-related factors as a possible
substitution to compensate for decreased angiogenic/circulatory factors. Furthermore, it also
appears that the increase in protein synthesis serves as a cautionary measure in the event of a
decrease in blood flow, the placenta is capable of signaling for enhanced nutrient and nutrienttransported uptake. On the macroscopic level, this compensatory effect appears to be at play. On
the other hand, nutrient restriction may be too overwhelming in the case of results from other
authors where manifestations in placental characteristics have led to detrimental effects in
offspring (Bernal et al. 2010; Lekatz et al. 2010b, Lemley et al. 2012). Less emphasis is placed
on developmental programming after birth due to the smaller ‘window’ of developmental
plasticity, garnering less instances of manifestation. However, from the fewer studies researched,
the postnatal phase is still a critical time for altering developmental outcomes (Bartol et al.,
1995; Chen et al. 2011).
The overwhelming majority of negative effects of programming warrant investigation of
potential mitigators or therapeutics. Melatonin has potent properties geared towards vasodilation,
antioxidant capacity, and hormone signal pathways that activate transcription factors. In addition,
it plays an important role in regulation of circadian factors, which are also emerging in research
to have severe effects on physiological characteristics in tissues such as muscle and adipose.
Previously, melatonin supplementation has been observed to increase calf growth and body
weight (Brockus et al., 2016b). In addition, testicular measurements were shown to increase in
offspring from dams treated with melatonin (McCarty et al., 2018). In the current study,
melatonin implants administered during mid- to late gestation and during the first three months
after parturition, did not increase performance. However, it was noted that plasma melatonin
levels were not different in melatonin-treated versus control dams. This is believed to be due to
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the time of year paired with the geographical region where the study was conducted. The
postnatal group was established to have increased plasma levels in the melatonin-treated calves
versus control calves. However, as mentioned, this did not alter performance. This suggest that
the prenatal period may be the most suitable time for melatonin supplementation and that the
postnatal period may be too late to observe differences.
In the case of treating melatonin to dams along with dietary restriction during two
different seasons, melatonin appears to mediate lipid and muscle metabolism in fetal loin muscle.
In the first trial, there appears to be a programming effect in which the fetus is preparing for the
colder months. Also, with an already restricted diet from the dam, the fetus appears to be altering
molecular mechanisms toward adipogenesis and lipogenesis in order to have sufficient fat
reserves for thermogenesis and overall energy after birth. In the case of the summer trial, there
was no favor towards adipogenesis, therefore, it appears that there is a higher differentiation of
cells geared towards increasing myogenesis instead. There appears to be melatonin-mediated
pathways in accordance with circadian rhythms; however there also appear to be melatoninindependent mechanisms at play. The limited changes in core clock genes during the second trial
suggest that these mechanisms are vast, with evidence of thousands of circadian factors being
involved in altering muscle and adipose metabolism (Hodge et al., 2015). Further studies are
warranted as it is hypothesized that this increase in myogenic factors may also involve the
influence of melatonin-dependent and independent circadian patterns, along with feed restriction,
on metabolic processes including glucose and amino acid homeostasis.
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APPENDIX A
ANALYSIS OF DIFFERENTIALLY EXPRESSED GENES (DEG) IN BOVINE
PLACENTOMES OF RES GROUP AT DAY 240 OF GESTATION
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Table A.1

Analysis of differentially expressed genes (DEG) in bovine placentomes of RES group at day 240 of gestation
(downregulation) at P ≤ 0.0001

Gene ID

Gene Name

Gene Description

log2FoldChange padj

100124505

PDE4B

phosphodiesterase 4B

-0.617

0.0000766

stomatin

-0.57329

0.0000401

100125834 STOM
100139508

NAV2

neuron navigator 2

-0.45829

0.0000377

100140945

CASP9

caspase 9

-0.30342

0.0000111

100141021

CYFIP1

cytoplasmic FMR1 interacting
protein 1

-0.29161

0.0000789

100299743

NRARP

Notch-regulated ankyrin repeat
protein

-0.76649

3.76E-09

100336551

ABCC9

ATP binding cassette subfamily C
member 9

-0.82844

2.55E-06

ABCC6

ATP binding cassette subfamily C
member 6

-0.52803

9.35E-06

100533525

BERV-K1

RNA export protein-like protein of
BERV-K1

-0.63965

4.54E-06

100848012

ID4

inhibitor of DNA binding 4

-0.77558

0.0000347

LTBP4

latent transforming growth factor
beta binding protein 4

-0.62451

1.06E-06

100337270

100848191
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Table A.1 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange padj

100848491

COL5A1

collagen type V alpha 1 chain

-1.102

1.89E-06

101907085

ubiquitin carboxyl-terminal
LOC101907085 hydrolase 17-like protein 6

-1.12

0.0000201

101907857

leukocyte immunoglobulin-like
LOC101907857 receptor subfamily B member 3

-1.167

3.51E-06

112441539

LOC112441539 putative SEC14-like protein 6

-0.54043

0.000071

112443749

LOC112443749 uncharacterized LOC112443749

-1.1183

1.59E-07

112448335

LOC112448335 small Cajal body-specific RNA 7

-1.3733

7.05E-08

112448763

KCNG3

potassium voltage-gated channel
modifier subfamily G member 3

-0.76679

5.22E-06

280781

ELN

elastin

-0.93635

0.0000854

280826

IL6

interleukin 6

-0.85922

6.57E-06

280841

LOX

lysyl oxidase

-0.99455

0.0000132

280847

LUM

lumican

-0.83596

0.0000728

280873

MX2

MX dynamin like GTPase 2

-1.068

0.0000529

281002

AOC3

amine oxidase, copper containing 3

-0.75587

0.0000456

281094

CSF1

colony stimulating factor 1

-0.50272

0.0000467

281136

LPAR1

lysophosphatidic acid receptor 1

-1.0558

0.0000179
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Table A.1 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange padj

281154

FBN1

fibrillin 1

-0.72319

0.0000753

281301

MCAM

melanoma cell adhesion molecule

-0.61034

0.0000359

281407

PLAT

plasminogen activator, tissue type

-0.82581

9.53E-08

281499

SPP1

secreted phosphoprotein 1

-1.0732

3.3E-07

281607

AGTR1

angiotensin II receptor type 1

-0.7911

0.0000296

281879

ITPR3

inositol 1,4,5-trisphosphate
receptor type 3

-1.2519

1.94E-13

281915

MMP14

matrix metallopeptidase 14

-1.0055

1.09E-09

281969

PDE1A

phosphodiesterase 1A

-1.004

4.54E-06

282077

SPARC

secreted protein acidic and cysteine
rich

-0.61171

0.0000666

282136

GRK3

G protein-coupled receptor kinase
3

-1.0226

0.0000147

282191

COL4A1

collagen type IV alpha 1 chain

-0.67525

0.0000152

282194

COL6A2

collagen type VI alpha 2 chain

-1.0041

0.0000789

282360

SLC4A4

solute carrier family 4 member 4

-1.3332

1.63E-07

GUCY1B1

guanylate cyclase 1 soluble subunit
beta 1

-0.76494

9.39E-06

282433
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Table A.1 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange padj

282661

CD47

CD47 molecule

-0.39414

0.0000692

282662

VCAN

versican

-1.0043

0.0000366

282866

SPON1

spondin 1

-1.0478

2.79E-07

326285

FGF10

fibroblast growth factor 10

-1.0913

0.0000214

327711

CTSS

cathepsin S

-0.71722

0.0000658

338037

MYLK

myosin light chain kinase

-0.81882

8.9E-07

352958

CTSC

cathepsin C

-0.80201

0.000016

407183

PFKFB3

6-phosphofructo-2-kinase/fructose2,6-biphosphatase 3

-0.64489

0.0000217

407237

TLR6

toll like receptor 6

-0.5135

0.0000893

408000

SEPT7

septin 7

-0.2626

7.01E-06

445417

FZD1

frizzled class receptor 1

-0.82983

7.42E-06

445418

FZD6

frizzled class receptor 6

-0.40649

9.08E-06

493779

RN18S1

18S ribosomal RNA

-0.71442

9.13E-06

497031

SLC2A12

solute carrier family 2 member 12

-0.66449

0.0000169

504235

STEAP3

STEAP3 metalloreductase

-0.33846

3.91E-08

504513

SH3D21

SH3 domain containing 21

-0.9009

4.06E-09
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Table A.1 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange padj

504531

PIK3CD

phosphatidylinositol-4,5bisphosphate 3-kinase catalytic
subunit delta

-0.48642

1.06E-06

504721

CCDC68

coiled-coil domain containing 68

-0.85522

0.0000209

504741

COLEC12

collectin subfamily member 12

-0.81262

0.0000461

505543

STAB1

stabilin 1

-0.75247

0.0000209

506075

ARHGEF25

Rho guanine nucleotide exchange
factor 25

-0.99715

0.0000163

506122

MTMR11

myotubularin related protein 11

-0.81113

0.0000772

506538

SPECC1

sperm antigen with calponin
homology and coiled-coil domains
1

-0.51715

0.0000525

507119

PFKP

phosphofructokinase, platelet

-0.37812

5.91E-06

507459

SLC52A3

solute carrier family 52 member 3

-0.50606

0.0000685

508943

MAP3K3

mitogen-activated protein kinase
kinase kinase 3

-0.39644

0.000041

509221

DAB2

DAB2, clathrin adaptor protein

-0.68879

0.0000789

509295

RIN1

Ras and Rab interactor 1

-1.1096

0.0000202

509808

LIPG

lipase G, endothelial type

-0.93964

1.14E-06
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Table A.1 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange padj

510554

PCDH17

protocadherin 17

-0.66631

0.0000222

511433

DLC1

DLC1 Rho GTPase activating
protein

-0.44632

0.0000579

511774

C1QTNF1

C1q and TNF related 1

-0.90592

9.17E-08

512019

ANGPTL2

angiopoietin like 2

-0.83869

1.03E-13

512302

CDH13

cadherin 13

-0.92301

0.0000236

512450

SH3GL2

SH3 domain containing GRB2 like
2, endophilin A1

-0.65292

0.0000313

513572

ERAP2

endoplasmic reticulum
aminopeptidase 2

-0.92776

2.13E-06

513902

SMURF1

SMAD specific E3 ubiquitin
protein ligase 1

-0.25717

0.0000895

513920

STYK1

serine/threonine/tyrosine kinase 1

-0.49061

5.91E-06

515128

MFSD4A

major facilitator superfamily
domain containing 4A

-0.55669

7.05E-08

515303

TCF7L1

transcription factor 7 like 1

-0.29534

3.2E-08

HSPA12B

heat shock protein family A
(Hsp70) member 12B

-0.35663

0.0000621

515590
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Table A.1 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange padj

515621

PIK3R6

phosphoinositide-3-kinase
regulatory subunit 6

-0.67591

0.0000114

516287

CYB5R1

cytochrome b5 reductase 1

-0.68646

2.25E-14

516730

OLFML2A

olfactomedin like 2A

-0.9078

2.09E-08

516840

SLC43A3

solute carrier family 43 member 3

-0.54204

0.0000243

516875

IPCEF1

interaction protein for cytohesin
exchange factors 1

-0.79399

0.0000119

517232

RECK

reversion inducing cysteine rich
protein with kazal motifs

-0.71478

0.0000715

518914

LAMC3

laminin subunit gamma 3

-0.80843

0.0000193

520530

MDFIC

MyoD family inhibitor domain
containing

-0.45995

0.0000772

520918

SLC35A3

solute carrier family 35 member
A3

-0.47509

3.73E-06

521326

HMCN1

hemicentin 1

-1.1936

3.26E-08

521504

KDM7A

lysine demethylase 7A

-0.59452

6.06E-07

522155

IL6ST

interleukin 6 signal transducer

-0.72304

2.62E-06

522383

NES

nestin

-0.72266

1.59E-07

523184

SOSTDC1

sclerostin domain containing 1

-1.3742

3.46E-08
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Table A.1 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange padj

523755

ITGA11

integrin subunit alpha 11

-0.84359

0.0000938

524813

FOXF1

forkhead box F1

-0.59662

0.0000378

525579

OTUD7B

OTU deubiquitinase 7B

-0.68899

0.0000192

525908

LDLRAD3

low density lipoprotein receptor
class A domain containing 3

-0.93154

9.05E-06

525937

GDA

guanine deaminase

-0.89081

4.06E-06

527140

CALCRL

calcitonin receptor like receptor

-0.70884

1.99E-06

FYN

FYN proto-oncogene, Src family
tyrosine kinase

-0.66233

0.0000461

HIST1H1B

H1.5 linker histone, cluster
member

-0.87203

0.000034

528815

LOC528815

pregnancy-associated glycoprotein
2

-0.83452

0.0000789

529939

LAMB3

laminin subunit beta 3

-1.2676

3.26E-08

530027

MAN1A1

mannosidase, alpha, class 1A,
member 1

-0.7087

0.0000943

530050

MYH11

myosin heavy chain 11

-0.92958

1.96E-06

BAMBI

BMP and activin membrane bound
inhibitor

-0.44834

0.000068

527263
527304

530147
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Table A.1 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange padj

530657

COL6A3

collagen type VI alpha 3 chain

-1.0683

1.78E-07

531877

PTPN12

protein tyrosine phosphatase, nonreceptor type 12

-0.43105

1.67E-07

531968

RNF44

ring finger protein 44

-0.33123

0.0000843

531974

NAV1

neuron navigator 1

-0.75835

0.0000194

532412

SGO2

shugoshin 2

-0.42868

0.0000579

532663

ENPP2

ectonucleotide
pyrophosphatase/phosphodiesterase
2
-0.63948

0.0000461

532684

LOXL2

lysyl oxidase like 2

-0.89142

2.52E-06

533403

PIAS2

protein inhibitor of activated STAT
2

-0.40496

0.0000658

533653

CSPG4

chondroitin sulfate proteoglycan 4

-0.792

6.69E-06

533916

ECM2

extracellular matrix protein 2

-0.96206

5.51E-06

534021

PGRMC2

progesterone receptor membrane
component 2

-0.33239

0.0000278

534032

AFAP1

actin filament associated protein 1

-0.57417

9.56E-08

534497

PMP22

peripheral myelin protein 22

-1.0054

8.96E-06

534650

RSPO3

R-spondin 3

-0.54628

5.27E-06
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Table A.1 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange padj

535310

FKBP10

FK506 binding protein 10

-0.70964

0.0000912

535372

SGCB

sarcoglycan beta

-0.76464

0.0000052

535868

BRSK2

BR serine/threonine kinase 2

-1.3591

3.39E-11

535916

SMAD7

SMAD family member 7

-0.45398

0.0000233

535975

UST

uronyl-2-sulfotransferase

-0.50739

0.0000943

COPG2

coatomer protein complex subunit
gamma 2

-0.57165

1.05E-19

537192

PRICKLE2

prickle planar cell polarity protein
2

-0.70135

0.0000193

538564

COL8A1

collagen type VIII alpha 1 chain

-1.0015

5.08E-07

538619

HEY2

hes related family bHLH
transcription factor with YRPW
motif 2

-0.784

0.0000575

539500

ZNF710

zinc finger protein 710

-0.44871

0.0000374

539960

STX11

syntaxin 11

-0.88059

5.24E-06

539997

MPEG1

macrophage expressed 1

-1.012

0.0000136

ARHGEF17

Rho guanine nucleotide exchange
factor 17

-0.68029

4.06E-06

536616

540026
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Table A.1 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange padj

540245

NR4A2

nuclear receptor subfamily 4 group
A member 2

-0.53247

0.0000432

540313

ETS1

ETS proto-oncogene 1,
transcription factor

-0.57348

4.91E-07

540462

AKTIP

AKT interacting protein

-0.35427

0.0000311

540509

RGS5

regulator of G protein signaling 5

-1.0423

0.0000236

540614

SEPT8

septin 8

-0.27874

0.0000996

541004

NRP2

neuropilin 2

-0.91481

7.61E-06

613639

TSPAN12

tetraspanin 12

-0.38463

0.000064

613658

AGMO

alkylglycerol monooxygenase

-0.97

0.0000238

614243

TMEM65

transmembrane protein 65

-0.72971

0.0000278

614583

SERTAD4

SERTA domain containing 4

-0.35398

0.0000384

614717

B3GNT9

UDP-GlcNAc:betaGal beta-1,3-Nacetylglucosaminyltransferase 9

-0.90621

2.43E-07

615467

LRRC32

leucine rich repeat containing 32

-0.68167

8.44E-06

615582

GGT1

gamma-glutamyltransferase 1

-0.83249

6.06E-07

615727

DUSP8

dual specificity phosphatase 8

-0.45974

6.39E-07
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Table A.1 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange padj

615907

FAM102A

family with sequence similarity
102 member A

-0.41213

0.0000359

616767

PRRG4

proline rich and Gla domain 4

-0.52293

0.0000345

618054

PROM1

prominin 1

-0.85682

0.0000336

618437

EXD3

exonuclease 3'-5' domain
containing 3

-0.44656

0.0000377

767910

PLAC8

placenta-specific 8

-1.0742

0.0000195

767991

RNF24

ring finger protein 24

-0.58622

2.93E-06

781117

SLC46A3

solute carrier family 46 member 3

-1.0189

1.7E-10

KIRREL1

kirre like nephrin family adhesion
molecule 1

-0.7455

0.0000417

781772

FAM25A

family with sequence similarity 25
member A

-1.0636

6.29E-06

783920

LOC783920

interferon-induced very large
GTPase 1-like

-1.2532

1.32E-06

785475

CDH11

cadherin 11

-1.1135

4.28E-06

786490

EMP1

epithelial membrane protein 1

-0.64233

3.51E-06

786844

MXRA5

matrix remodeling associated 5

-1.0949

2.17E-07

787194

HOXA13

homeobox A13

-0.57654

0.0000261

781667
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Table A.1 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange padj

787326

GGT5

gamma-glutamyltransferase 5

-0.8233

1.51E-06

787578

MRC1

mannose receptor C-type 1

-0.86827

0.0000122

788252

ADGRL1

adhesion G protein-coupled
receptor L1

-0.4822

0.0000403

788637

IQCN

IQ motif containing N

-0.66024

3.61E-06

789485

NOTCH3

notch receptor 3

-0.76866

0.0000517
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Table A.2

Analysis of differentially expressed genes (DEG) in bovine placentomes of RES group at day 240 of gestation
(upregulation) at P ≤ 0.0001.

Gene ID

Gene Name

Gene Description

log2FoldChange

padj

540437

MYO18B

myosin XVIIIB

1.9768

3.17E-20

787307

KCNK13

potassium two pore domain channel
subfamily K member 13

1.5389

2.13E-10

338050

SERPINA5

serpin family A member 5

1.452

6.74E-23

518176

ZSCAN31

zinc finger and SCAN domain
containing 31

1.4261

4.05E-13

504975

TLL2

tolloid like 2

1.4061

8.47E-20

112441462 SERPINA5

serpin family A member 5

1.3721

4.09E-12

614113

C7H5orf46

chromosome 7 C5orf46 homolog

1.3273

1.32E-07

614656

LOC614656

pregnancy-associated glycoprotein
1-like

1.3159

9.84E-10

512741

H3F3C

H3 histone, family 3C

1.2879

1.04E-13

SPINK5

serine peptidase inhibitor, Kazal
type 5

1.2531

1.06E-06

1.2478

2.76E-07

526637

dynein light chain Tctex-type 1
101902787 LOC101902787 pseudogene
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

521685

GSTA5

glutathione S-transferase alpha 5

1.2447

5.78E-07

614741

LOC614741

formin-2

1.1895

3.73E-06

515913

TBATA

thymus, brain and testes associated

1.1853

4.83E-06

327712

CCL5

C-C motif chemokine ligand 5

1.1791

2.73E-06

407161

SLC12A1

solute carrier family 12, member 1

1.1788

6.29E-06

60S ribosomal protein L15
101903301 LOC101903301 pseudogene

1.1537

6.16E-06

281268

KRT5

keratin 5

1.1531

1.23E-10

539420

ELF5

E74 like ETS transcription factor 5

1.144

1.1E-06

511942

GLP2R

glucagon like peptide 2 receptor

1.1359

3.17E-06

100296459 C18H19orf18

chromosome 18 C19orf18 homolog

1.1319

1.22E-07

615697

LOC615697

cytochrome P450 2F3

1.1288

1.25E-05

SERPINA3-1

serpin peptidase inhibitor, clade A
(alpha-1 antiproteinase, antitrypsin),
member 3
1.1272

4.06E-06

INA

internexin neuronal intermediate
filament protein alpha

1.1199

1.22E-05

CHI3L1

chitinase 3-like 1 (cartilage
glycoprotein-39)

1.1163

5.61E-07

286804
532236
286869
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

515263

ALDOB

aldolase, fructose-bisphosphate B

1.1142

2.01E-05

532015

ELOVL4

ELOVL fatty acid elongase 4

1.1095

1.87E-06

782061

LOC782061

aldo-keto reductase family 1,
member C1-like

1.1037

1.32E-07

408009

APOC3

apolipoprotein C-III

1.1035

2.01E-05

614257

TMEM252

transmembrane protein 252

1.0942

3.37E-05

100298064 LOC100298064 hepatitis A virus cellular receptor 1

1.0895

3.59E-05

112449293 LOC112449293 dihydrodiol dehydrogenase 3-like

1.0687

3.45E-05

ADP-ribosylation factor-like
protein 6-interacting protein 1
101904039 LOC101904039 pseudogene

1.0621

5.25E-05

791042

1.0566

3.38E-05

112446680 LOC112446680 tubulin alpha-1C chain-like

1.0561

6.66E-05

790891

DNAH9

dynein axonemal heavy chain 9

1.0459

4.37E-06

789898

LOC789898

dimethylaniline monooxygenase
[N-oxide-forming] 5-like

1.0442

8E-05

100336740 ANKRD45

ankyrin repeat domain 45

1.0399

7.38E-05

617851

peptidyl arginine deiminase 2

1.0324

3.2E-08

MIR29B-2

PADI2

microRNA 29b-2
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

504611

EPS8L3

EPS8-like 3

1.0262

6.71E-05

LOC613966

group 10 secretory phospholipase
A2

1.0242

1.74E-12

1.0185

5.92E-05

1.0053

1.93E-05

0.98741

9.38E-05

LOC509705

sentrin-specific protease 3
pseudogene

0.95666

9.25E-05

NXPE2

neurexophilin and PC-esterase
domain family, member 2

0.94792

6.8E-05

538495

ILDR1

immunoglobulin like domain
containing receptor 1

0.94667

4.19E-14

505664

FRAT1

FRAT regulator of WNT signaling
pathway 1

0.94612

2.25E-05

535704

FKBP5

FK506 binding protein 5

0.92697

8.85E-07

514076

CFB

complement factor B

0.91866

1.16E-05

613966

pleckstrin homology domaincontaining family B member 2
112447770 LOC112447770 pseudogene
512164

ITIH2

inter-alpha-trypsin inhibitor heavy
chain 2

butyrophilin subfamily 1 member
112443756 LOC112443756 A1-like
509705
782358
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

508379

SMOC1

SPARC related modular calcium
binding 1

0.9175

1.23E-10

537379

RBP1

retinol binding protein 1

0.90364

3.13E-05

540175

GPRIN2

G protein regulated inducer of
neurite outgrowth 2

0.88046

2.72E-06

533481

TAT

tyrosine aminotransferase

0.87087

2.8E-05

282879

HGF

hepatocyte growth factor

0.83849

2.21E-05

281806

GSTP1

glutathione S-transferase pi 1

0.83742

1.23E-10

509351

FAM111B

family with sequence similarity 111
member B

0.83538

3.41E-06

528508

DTX4

deltex E3 ubiquitin ligase 4

0.82671

2.63E-09

617215

PTPN18

protein tyrosine phosphatase, nonreceptor type 18

0.82646

3.2E-05

281174

FUT1

fucosyltransferase 1

0.82539

9.02E-05

327709

GSTM1

glutathione S-transferase M1

0.82146

3.76E-06

512045

C5

complement component 5

0.81762

2.06E-05

514667

MST1

macrophage stimulating 1

0.81479

1.51E-10

512512

DNASE1L3

deoxyribonuclease 1 like 3

0.81374

2.4E-07
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

280740

CA2

carbonic anhydrase II

0.80896

1.04E-10

100336456 LSAMP

limbic system associated membrane
protein

0.80715

9.97E-07

404053

TUBA1A

tubulin, alpha 1a

0.8038

2.18E-08

C2CD4B

C2 calcium dependent domain
containing 4B

0.80227

5.67E-05

518047

SLCO1C1

solute carrier organic anion
transporter family member 1C1

0.76411

1.35E-07

513362

NPNT

nephronectin

0.7617

1.51E-06

781942

SECTM1

secreted and transmembrane 1

0.75639

6.5E-12

538479

KCNJ12

potassium voltage-gated channel
subfamily J member 12

0.72818

2.4E-07

509209

ACSF3

acyl-CoA synthetase family
member 3

0.72166

3.78E-06

613635

C22H3orf14

chromosome 22 C3orf14 homolog

0.71067

2.13E-06

783452

NRG2

neuregulin 2

0.69835

4.56E-06

618020

MCRIP2

MAPK regulated corepressor
interacting protein 2

0.69188

4.28E-06

281194

GJB1

gap junction protein beta 1

0.68033

8.67E-11

529849
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

282089

TGFB1

transforming growth factor beta 1

0.67597

1.08E-05

526872

ANKRD29

ankyrin repeat domain 29

0.67231

4.53E-05

782069

GPR27

G protein-coupled receptor 27

0.66357

2.17E-05

508098

LOC508098

uncharacterized LOC508098

0.65447

1.52E-06

511447

WDR54

WD repeat domain 54

0.6471

1.72E-07

517432

IGSF9B

immunoglobulin superfamily
member 9B

0.64338

1.14E-05

616332

NUDT8

nudix hydrolase 8

0.6411

1.96E-06

574400

SF3B5

splicing factor 3b subunit 5

0.6389

3.1E-06

513446

BANP

BTG3 associated nuclear protein

0.63481

2.45E-08

510379

MON1B

MON1 homolog B, secretory
trafficking associated

0.62939

1.24E-08

507199

MVB12A

multivesicular body subunit 12A

0.62561

7.72E-05

528615

DNAJA4

DnaJ heat shock protein family
(Hsp40) member A4

0.62509

4.05E-06

280750

CLU

clusterin

0.62167

3.1E-06

614409

AIG1

androgen induced 1

0.61639

5.81E-05
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

613547

RAMP3

receptor activity modifying protein
3

0.60599

1.04E-11

281643

BCAT2

branched chain amino acid
transaminase 2

0.60532

7.99E-05

526937

DCXR

dicarbonyl/L-xylulose reductase

0.59924

4.37E-06

100336419 UROC1

urocanate hydratase 1

0.59845

8.47E-11

534628

NMRAL1

NmrA like redox sensor 1

0.5958

3.06E-05

511082

ACAT1

acetyl-CoA acetyltransferase 1

0.58917

7.69E-05

540124

DKKL1

dickkopf like acrosomal protein 1

0.58465

4.27E-05

493729

WNT2

Wnt family member 2

0.57819

3.58E-05

281650

BLVRB

biliverdin reductase B

0.57672

2.32E-05

511830

CDX1

caudal type homeobox 1

0.57567

7.61E-05

100297709 PNPLA3

patatin-like phospholipase domain
containing 3

0.57461

8.49E-05

100297905 NINL

ninein-like

0.55641

2.61E-05

515784

CKAP4

cytoskeleton associated protein 4

0.55536

8E-06

505294

SLC39A3

solute carrier family 39 member 3

0.55277

3.2E-06
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

540456

TPGS2

tubulin polyglutamylase complex
subunit 2

0.54789

1.35E-07

506043

FKBP11

FK506 binding protein 11

0.54528

5.99E-05

513453

TALDO1

transaldolase 1

0.54278

6.11E-11

539222

PBX3

PBX homeobox 3

0.54192

1.67E-05

529823

LOC529823

C2 calcium-dependent domaincontaining protein 4A

0.53956

3.65E-05

507080

PIGL

phosphatidylinositol glycan anchor
biosynthesis class L

0.53833

2.79E-07

506946

DTYMK

deoxythymidylate kinase

0.53805

4.01E-05

507491

SLC26A11

solute carrier family 26 member 11

0.53622

1.18E-06

337901

PAG7

pregnancy-associated glycoprotein
7

0.5345

5.29E-05

512041

EBNA1BP2

EBNA1 binding protein 2

0.52766

2.92E-08

tigger transposable element-derived
101903649 LOC101903649 protein 1-like

0.52599

1.39E-05

535056

RPL8

ribosomal protein L8

0.52427

2.73E-06

519017

APRT

adenine phosphoribosyltransferase

0.52273

9.86E-05

509684

SLC25A39

solute carrier family 25 member 39

0.52128

9.39E-10
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

518114

GPC1

glypican

0.50977

1.96E-06

533917

GSTA4

glutathione S-transferase alpha 4

0.50551

4.74E-07

522875

NKIRAS1

NFKB inhibitor interacting Ras like
1

0.5053

6.42E-05

281811

HADHB

hydroxyacyl-CoA dehydrogenase
trifunctional multienzyme complex
subunit beta

0.50441

1.97E-20

512756

COPS6

COP9 signalosome subunit 6

0.50305

3.24E-06

507942

MGC152281

uncharacterized LOC507942

0.50284

2.98E-05

326600

ARPC1B

actin related protein 2/3 complex
subunit 1B

0.50154

4.56E-05

790210

LRR1

leucine rich repeat protein 1

0.49115

6.71E-05

531564

SLC29A2

solute carrier family 29 member 2

0.48927

9.14E-09

615431

MRPS6

mitochondrial ribosomal protein S6

0.48669

1.78E-05

281810

HADHA

hydroxyacyl-CoA dehydrogenase
trifunctional multienzyme complex
subunit alpha

0.47965

6.11E-11

281748

ECHS1

enoyl-CoA hydratase, short chain 1

0.4762

8.47E-11
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

512024

CACFD1

calcium channel flower domain
containing 1

0.47375

6.8E-05

504438

SSR4

signal sequence receptor subunit 4

0.47027

4.22E-05

511913

HSPD1

heat shock 60kDa protein 1
(chaperonin)

0.465

4.44E-08

616838

CCDC8

coiled-coil domain containing 8

0.46354

3.49E-06

MRPS34

mitochondrial ribosomal protein
S34

0.46306

7.88E-05

327696

SDHC

succinate dehydrogenase complex
subunit C

0.46206

1.54E-08

281420

PPID

peptidylprolyl isomerase D

0.46035

8.98E-07

337897

PAG2

pregnancy-associated glycoprotein
2

0.45819

2.42E-06

507945

DUT

deoxyuridine triphosphatase

0.45207

9.38E-05

515371

PDZD11

PDZ domain containing 11

0.45098

4.85E-05

520277

CALM3

calmodulin 3

0.44782

3.26E-07

613927

PDIA6

protein disulfide isomerase family
A member 6

0.44577

7.5E-07

515877

RBBP8NL

RBBP8 N-terminal like

0.44413

9.1E-08

618357

162

Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

534672

FAM20C

FAM20C golgi associated secretory
pathway kinase

0.43691

9.56E-06

616317

STMN1

stathmin 1

0.43681

5.15E-05

RPLP0

ribosomal protein lateral stalk
subunit P0

0.43641

4.36E-06

507318

FLVCR2

feline leukemia virus subgroup C
cellular receptor family, member 2

0.43553

5.46E-08

511424

C6H4orf19

chromosome 6 C4orf19 homolog

0.43228

1.79E-05

TVP23B

trans-golgi network vesicle protein
23 homolog B

0.43218

2.61E-06

511469

ALDH3B1

aldehyde dehydrogenase 3 family
member B1

0.43047

2.38E-06

533892

RPS9

ribosomal protein S9

0.42684

3.56E-05

618505

AP5S1

adaptor related protein complex 5
sigma 1 subunit

0.42552

2.13E-05

513128

RPL7A

ribosomal protein L7a

0.41789

7.83E-05

541266

SLC22A5

solute carrier family 22 member 5

0.41577

2.5E-05

530409

PHB

prohibitin

0.41266

1.97E-05

613357

ERP29

endoplasmic reticulum protein 29

0.40926

5.34E-06

286868

513550
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

533595

TLE2

TLE family member 2,
transcriptional corepressor

0.40853

3.77E-05

790470

PRP2

prolactin-related protein 2

0.4058

1.59E-05

532560

SLC25A15

solute carrier family 25 member 15

0.40548

7.05E-08

505355

ECI2

enoyl-CoA delta isomerase 2

0.40305

6.58E-05

513586

MPI

mannose phosphate isomerase

0.39891

9.61E-05

281832

HSP90AA1

heat shock protein 90 alpha family
class A member 1

0.39828

2.15E-07

507151

RPL15

ribosomal protein L15

0.3934

4.61E-06

539276

HTATIP2

HIV-1 Tat interactive protein 2

0.38663

1.14E-05

616337

PLPP5

phospholipid phosphatase 5

0.37916

1.36E-05

541142

LANCL2

LanC like 2

0.37823

1.1E-06

539149

TUBB4B

tubulin beta 4B class IVb

0.37769

9.25E-06

514759

ALDH18A1

aldehyde dehydrogenase 18 family
member A1

0.37709

1.69E-05

616071

SLC6A11

solute carrier family 6 member 11

0.37512

8.43E-05

541250

PSRC1

proline and serine rich coiled-coil 1

0.37226

6.75E-05
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

532389

MRPL44

mitochondrial ribosomal protein
L44

0.36744

6.63E-06

282421

CTNNBL1

catenin beta like 1

0.36363

7.72E-05

538943

GINS3

GINS complex subunit 3

0.36185

3.17E-05

507986

MOCS2

molybdenum cofactor synthesis 2

0.35932

2.75E-05

505144

CHORDC1

cysteine and histidine rich domain
containing 1

0.35326

5.34E-06

317658

HMGCL

3-hydroxymethyl-3-methylglutarylCoA lyase

0.35234

1.1E-06

281813

FUNDC2

FUN14 domain containing 2

0.35137

1.09E-05

404155

LAPTM4B

lysosomal protein transmembrane 4
beta

0.34873

7.28E-05

618141

ZNF3

zinc finger protein 3

0.34843

3.49E-06

615552

MGST2

microsomal glutathione Stransferase 2

0.34365

3.62E-05

510347

MRPL15

mitochondrial ribosomal protein
L15

0.3407

7.29E-06

767874

HSP90AB1

heat shock protein 90 alpha family
class B member 1

0.33905

6.69E-06
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

514493

DTD1

D-tyrosyl-tRNA deacylase 1

0.33788

2.04E-05

MIPEP

mitochondrial intermediate
peptidase

0.33445

3.47E-05

ABCB6

ATP binding cassette subfamily B
member 6

0.3244

3.49E-06

504735

CCT3

chaperonin containing TCP1
subunit 3

0.31449

8.43E-05

527467

GFM2

G elongation factor mitochondrial 2

0.30916

3.92E-06

522980

USP2

ubiquitin specific peptidase 2

0.30883

7.72E-05

AP3S2

adaptor related protein complex 3
sigma 2 subunit

0.30878

5.88E-06

IMPDH1

inosine monophosphate
dehydrogenase 1

0.30553

3.58E-05

613907

BHLHE41

basic helix-loop-helix family
member e41

0.30511

5.99E-05

617109

STIP1

stress induced phosphoprotein 1

0.29707

2.08E-05

513558

BSCL2

BSCL2, seipin lipid droplet
biogenesis associated

0.28824

5.29E-05

505579

IFT46

intraflagellar transport 46

0.287

4.01E-05

517531
783257

508867
504305
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Table A.2 (continued)
Gene ID

Gene Name

Gene Description

log2FoldChange

padj

511614

GPAT4

glycerol-3-phosphate
acyltransferase 4

0.27155

3.66E-05

514355

CCT7

chaperonin containing TCP1
subunit 7

0.25657

9.26E-05

282578

ATP5F1A

ATP synthase F1 subunit alpha

0.25179

8.4E-05

613338

IDH3B

isocitrate dehydrogenase 3
(NAD(+)) beta

0.25147

8.54E-05

512534

HM13

histocompatibility minor 13

0.24652

2.21E-05
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APPENDIX B
RELATIVE QUANTIFICATION OF FETAL LOIN MUSCLE GENE EXPRESSION FROM
SAMPLES TAKEN AT DAY 240 OF GESTATION IN FALL 2019 AND SUMMER
2020 TRIALS
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Table B.1
Item
ARNTL
CLOCK
CRY1
CRY2
PER2
ADIPOQ
AMPK
SCD
IGF1
IGF2
IGF2R
MYF5
MYF6
MYOD1
MYOG

Relative quantification of fetal loin muscle gene expression from samples taken at day 240 of gestation in fall 2019 trial
ADQ
1.324
1.062
1.008
1.169
1.289
0.984
1.183
1.733
1.368
1.447
0.352
1.019
0.881
1.735
1.295

RES
1.020*
0.908†
0.821†
1.036
1.482
0.952
0.905*
1.878
1.140
1.211
0.311
1.021
0.814
1.184*
0.906†

CON
1.324
1.082
0.970
1.194
1.600
1.036
1.134
1.992
1.207
1.271
0.350
1.122
0.954
1.502
1.186

MEL
1.020*
0.888*
0.859
1.010
1.171*
0.900
0.953†
1.619
1.301
1.387
0.314
0.918
0.742*
1.417
1.014

AM
1.268
1.016
0.860
1.171
1.194
0.715
1.052
1.844
1.281
1.389
0.338
1.098
0.842
1.452
1.090

PM
1.076*
0.954
0.969
1.034
1.578
1.240
1.035
1.767
1.227
1.270
0.326
0.942
0.853
1.467
1.110
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SE
0.047
0.055
0.065
0.084
0.143
0.273
0.070
0.297
0.131
0.101
0.026
0.085
0.062
0.108
0.145

Diet
0.0003
0.0602
0.0531
0.2718
0.3480
0.9370
0.0090
0.7326
0.2286
0.1055
0.2776
0.9820
0.4475
0.0013
0.0691

Trt
0.0003
0.0213
0.2424
0.1323
0.0446
0.7308
0.0770
0.383
0.6194
0.4220
0.3339
0.1031
0.0228
0.5837
0.4096

Time
0.0142
0.4437
0.2506
0.2603
0.0698
0.1880
0.8675
0.8561
0.7730
0.4476
0.7528
0.2091
0.9022
0.9232
0.9209

Table B.2

Item
IGF1R
Item
PPARG

Relative quantification of fetal loin muscle gene expression from samples taken at day 240 of gestation in fall 2019 trial
(interactions)
ADQCON
1.121ab
CONAM
0.202a

RESCON
1.276a
CONPM
0.139ab

ADQMEL
1.276a
MELAM
0.127b

RESMEL
0.793b
MELPM
0.162ab

SE
0.152

Diet
0.292

Trt
0.294

Time
0.894

Diet*Trt

SE
0.021

Diet
0.338

Trt
0.206

Time
0.529

Trt*Time
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0.047

0.033

Table B.3
Item
CLOCK
CRY2
ADIPOQ
AMPK
CEBPA
PPARG
SCD
IGF1R
IGF2R
MYF5
MYOD1

Relative quantification of fetal loin muscle gene expression from samples taken at day 240 of gestation in summer 2020
trial
ADQ
2.832
3.582
6.591
1.677
2.921
2.609
1.777
1.858
2.269
2.051
2.157

RES
2.751
3.212
2.043
1.637
2.182
2.313
2.002
1.710
2.212
2.208
2.081

CON
2.910
3.400
5.959
1.703
2.362
2.875
1.862
1.899
2.319
2.143
2.131

MEL
2.672
3.394
2.675
1.611
2.741
2.047
1.917
1.669
2.162
2.116
2.107

AM
2.729
3.465
1.518
1.623
2.407
2.071
1.985
1.838
2.077
2.197
2.027

PM
2.854
3.329
7.116
1.691
2.696
2.851
1.793
1.730
2.404
2.062
2.211
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SE
0.235
0.279
3.776
0.099
0.874
0.378
0.272
0.145
0.202
0.245
0.134

Diet
0.8103
0.3596
0.4060
0.7810
0.5563
0.5861
0.5668
0.437
0.8462
0.6551
0.6629

Trt
0.4817
0.9883
0.5467
0.5238
0.7624
0.1379
0.8874
0.3016
0.5904
0.9382
0.9073

Time
0.7119
0.7327
0.3087
0.6373
0.8180
0.1606
0.6244
0.6524
0.2665
0.7018
0.4065

Table B.4

Relative quantification of fetal loin muscle gene expression from samples taken at day 240 of gestation in summer 2020
trial (interactions)

ADQItem
ADQ-AM PM
RES-AM RES-PM SE
Nut
Trt
Time
Diet*Time
a
b
b
b
ARNTL
3.859
2.158
2.592
2.713
0.257
0.184
0.740
0.006
0.002
a
ab
b
a
CRY1
2.637
2.109
1.974
2.885
0.331
0.865
0.691
0.571
0.043
b
b
b
a
PER2
1.574
1.839
1.386
2.526
0.251
0.321
0.138
0.010
0.089
ab
b
b
a
IGF2
2.036
1.810
1.682
2.355
0.175
0.594
0.793
0.218
0.019
MYF6
2.323b
2.216b
2.111b
2.9219a
0.139
0.089
0.591
0.056
0.006
c
a
ab
b
MYF6
1.931
2.776
2.503
2.361
0.147
0.089
0.591
0.056
0.010
Item

ADQ-CON-AM
ADQ-CON-PM
ADQ-MEL-AM
ADQ-MEL-PM
RES-CON-AM
RES-CON-PM
RES-MEL-AM
RES-MEL-PM

SE
Nut
Trt
Time
Diet*Trt*Time

IGF1
1.300
1.5771
3.055
1.1489
1.5605
1.6124
1.4484
1.8631
0.169125
0.2682
0.0421
0.1234
0.0041

MYOG
-2.1235
6.7436
-0.616
6.8423
-2.2927
6.2392
-1.4951
9.0311
0.762025
0.5079
0.0054
0.0006
0.0411
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APPENDIX C
RELATIVE QUANTIFICATION OF METABOLOMIC FCTORS TAKEN FROM LIVER
AND LOIN MUSCLE BIOPSIES OF CALVES AT DAY 210 (WEANING AGE), SEX
X TREATMENT INTERACTION OF HIP HEIGHT MEASUREMENTS IN
WEANED CALVES SUBJECTED TO PRENATAL AND POSTNATAL
MELATONIN SUPPLEMENTATION.
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Table C.1

Liver biopsy analysis taken from calves at weaning age (day 210) showing the relative quantification of metabolomic
factors

Item
preCON preMEL postCON postMEL SE
preTrt posTrt
AMPK
597.29
903.20
793.18
707.32 209.98
0.314
0.774
IGF1
2.85
3.64
3.33
3.15
0.766
0.474
0.872
IGF1R
216.44
223.46
220.94
218.96
67.37
0.942
0.934
PPARG 9603.03 14208.00 12717.00 11094.00 3324.84
0.339
0.733

Table C.2

Loin muscle biopsy analysis taken from calves at weaning age (day 210) showing the relative quantification of
metabolomic factors

Item
preCON preMEL postCON postMEL SE
preTrt posTrt
ADIPOQ
0.46
0.60
0.59
0.46
0.18
0.574
0.591
AMPK
0.91
0.75
0.77
0.89
0.06
0.060
0.140
IGF1
0.79
0.75
0.80
0.74
0.05
0.674
0.358
IGF1R
0.46
0.44
0.47
0.43
0.03
0.674
0.358
IGF2
1.06
1.10
1.09
1.07
0.07
0.703
0.830
IGF2R
0.30
0.27
0.27
0.30
0.03
0.511
0.526
MYF5
0.81
0.93
0.98
0.76
0.08
0.273
0.056
MYF6
0.91
0.92
0.93
0.90
0.06
0.932
0.721
MYOD1
1.26
1.25
1.41
1.11
0.11
0.957
0.054
PPARG
0.76
0.70
0.75
0.71
0.09
0.641
0.775
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Figure C.1

Figure depicting sex x treatment interaction (P = 0.007) in calves subjected to prenatal and postnatal treatments
(analyzed at day 210).
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